#  @PsychedVantage Psychedelic Vantage Psychedelic Vantage posts on X about $atai, $cybn, $cmps, $ghrs the most. They currently have [-------] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours. ### Engagements: [---] [#](/creator/twitter::1461655010958315520/interactions)  - [--] Week [-----] -45% - [--] Month [------] -80% - [--] Months [-------] +180% - [--] Year [-------] +491% ### Mentions: [--] [#](/creator/twitter::1461655010958315520/posts_active)  - [--] Week [--] -44% - [--] Month [--] -20% - [--] Months [---] +64% - [--] Year [---] +213% ### Followers: [-------] [#](/creator/twitter::1461655010958315520/followers)  - [--] Week [-----] +0.34% - [--] Month [-----] +1.10% - [--] Months [-----] +27% - [--] Year [-----] +75% ### CreatorRank: [---------] [#](/creator/twitter::1461655010958315520/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [exchanges](/list/exchanges) [currencies](/list/currencies) [countries](/list/countries) [us election](/list/us-election) [technology brands](/list/technology-brands) [travel destinations](/list/travel-destinations) [cryptocurrencies](/list/cryptocurrencies) [social networks](/list/social-networks) **Social topic influence** [$atai](/topic/$atai) #4, [$cybn](/topic/$cybn), [$cmps](/topic/$cmps) #7, [$ghrs](/topic/$ghrs) #3, [$mnmd](/topic/$mnmd), [atai life](/topic/atai-life) #5, [data](/topic/data), [announces](/topic/announces), [in the](/topic/in-the), [investment](/topic/investment) **Top accounts mentioned or mentioned by** [@atailife](/creator/undefined) [@cybininc](/creator/undefined) [@cangermayer](/creator/undefined) [@psychedalpha](/creator/undefined) [@c2412345](/creator/undefined) [@flobrand](/creator/undefined) [@larswilde](/creator/undefined) [@gilgameshrx](/creator/undefined) [@cangermayers](/creator/undefined) [@brandonjob23](/creator/undefined) [@4andahalffarm](/creator/undefined) [@advisorshares](/creator/undefined) [@insidepharma](/creator/undefined) [@beckleypsytech](/creator/undefined) [@waracken](/creator/undefined) [@bigdogback](/creator/undefined) [@compasspathway](/creator/undefined) [@smallpharma](/creator/undefined) [@mindsetpharma](/creator/undefined) [@atailifes](/creator/undefined) **Top assets mentioned** [Atai Life Sciences B.V. (ATAI)](/topic/$atai) [COMPASS Pathways plc (CMPS)](/topic/$cmps) [GH Research PLC (GHRS)](/topic/$ghrs) [Alto Neuroscience, Inc. (ANRO)](/topic/$anro) [AbbVie Inc (ABBV)](/topic/$abbv) [Axsome Therapeutics, Inc (AXSM)](/topic/$axsm) [Bitcoin (BTC)](/topic/bitcoin) [Johnson & Johnson (JNJ)](/topic/$jnj) ### Top Social Posts Top posts by engagements in the last [--] hours "Excited to announce the latest episode of our show with host Adam Tubero and guest Jim Gilligan exploring the groundbreaking TRP-8803 IV psilocin delivery system by Tryp Get ready for expert insights and a deep dive into Tryp. #TrypTherapeutics $TRYPF https://youtu.be/4eqUll2eOOI https://youtu.be/4eqUll2eOOI" [X Link](https://x.com/PsychedVantage/status/1625221088186703872) 2023-02-13T19:51Z [----] followers, [---] engagements "Leaked footage of an $ATAI investor waiting for phase 1/2a results from DemeRx that atai had originally anticipated coming out in early [----] (according to [----] earnings report)" [X Link](https://x.com/PsychedVantage/status/1659272952045608964) 2023-05-18T19:01Z [----] followers, [---] engagements "Alright @mathovermyth new [--] month highs for $GHRS and $MSSTF. Give us the TA🔥" [X Link](https://x.com/PsychedVantage/status/1666951386347581443) 2023-06-08T23:32Z [----] followers, [---] engagements "Following the release of this news on June 22nd $MSSTF is up 20% trading at a $30.58 million dollar market cap making a new [--] month high at .30 a share" [X Link](https://x.com/PsychedVantage/status/1673788511336423426) 2023-06-27T20:20Z [----] followers, [---] engagements "You would have thought it was a full trading day with the volume coming in on some of these names. $DMTTF leading the way alongside $CYBIN(how about that volume 👀). A fantastic day for $ATAI as well" [X Link](https://x.com/PsychedVantage/status/1675934672612737024) 2023-07-03T18:28Z [----] followers, [---] engagements "Recently Adam had the opportunity to receive a ketamine infusion at a clinic in New Jersey. In this video Adam gives a detailed description of his experience. We hope you enjoy" [X Link](https://x.com/PsychedVantage/status/1679203181115453440) 2023-07-12T19:02Z [---] followers, [---] engagements "while I do not hold $NUMI I am rooting for them and I admire the loyalty of the company's investor. So my question to the $NUMI bulls is: Bullish or bearish on Q3 results set to be released on Monday July 17th Bullish Bearish Bullish Bearish" [X Link](https://x.com/PsychedVantage/status/1680012386449620992) 2023-07-15T00:32Z [----] followers, [---] engagements "Portfolio as it stands today: 50% in $ATAI 40% in $GHRS and 10% in $MSSTF (not financial advice). Would love to hear the breakdown of everyone else's holdings if they are invested in the sector" [X Link](https://x.com/PsychedVantage/status/1681417219136184321) 2023-07-18T21:34Z [----] followers, [---] engagements "@V_arrell Jealous of your entry point in $ATAI. $4.11 DCA for me.(bought dip more aggressively over the last [--] years the more the stock dropped) How are you feeling about $NUMI after Q3 results Still trying to form an opinion on those results myself" [X Link](https://x.com/PsychedVantage/status/1681427760273846272) 2023-07-18T22:16Z [----] followers, [---] engagements "@AdvisorShares @mindmedco @COMPASSPathway @atai_life Don't forget $GHRS and $CYBN 😉. Still waiting for $MSSTF to be added to the ETF 🧐" [X Link](https://x.com/PsychedVantage/status/1681587362592161792) 2023-07-19T08:50Z [----] followers, [---] engagements "Despite releasing stellar phase 2a (small trial) results for SPLO26(Intravenous DMT). @SmallPharma $DMTTF is trading at an all time low today. Following this company very closely" [X Link](https://x.com/PsychedVantage/status/1681699825736138752) 2023-07-19T16:17Z [----] followers, [---] engagements "$MSET approaching its [--] week high while the rest of the sector lags behind. Gotta wonder what is cooking up for @MindsetPharma right now" [X Link](https://x.com/PsychedVantage/status/1689273790683885569) 2023-08-09T13:53Z [----] followers, [---] engagements "$MSET continues the uptrend. New [--] week high today. Psychedelics Performance [--] YR %: $MSET $CMPS $ATAI $PSYK https://t.co/B1o9uTADMx Psychedelics Performance [--] YR %: $MSET $CMPS $ATAI $PSYK https://t.co/B1o9uTADMx" [X Link](https://x.com/PsychedVantage/status/1694719514242580798) 2023-08-24T14:33Z [----] followers, [---] engagements "🧵Just had the chance to watch @CybinInc $CYBN's R&D day video. I was extremely impressed. My personal biggest takeaway: 57% of participants so far in the phase 1/2a trial of CYBOO3 rated the CYB003 experience as the most or top [--] most meaningful experiences of their lives" [X Link](https://x.com/PsychedVantage/status/1698773306529231210) 2023-09-04T19:01Z [---] followers, [----] engagements "In case you missed it here is our most recent interview with @insidepharma talking about @CybinInc's $CYBN acquisition of @SmallPharma $DMTTF. Point [--] recently bought over [--] million shares in $CYBN. This is big time news. CYB003 results coming soon. https://www.youtube.com/watchv=1OceEJRCECM&t=117s https://www.youtube.com/watchv=1OceEJRCECM&t=117s" [X Link](https://x.com/PsychedVantage/status/1703154769018208347) 2023-09-16T21:11Z [----] followers, [----] engagements "🧵Bull case for $CYBN from @Serotonin2arec(These are just opinions and not financial advice): CYB003 is already confirmed to be shorter acting than Comp360 and phase 1/2a interim data showed 57% of trial participants in the phase [--] portion rated the CYB003 experience as the" [X Link](https://x.com/PsychedVantage/status/1703911129494286669) 2023-09-18T23:17Z [---] followers, [----] engagements "From our friend @Kukeon2022: "Otsuka and Cybin called bottom" in the sector with Otsuka acquiring @MindsetPharma $MSET and @CybinInc $CYBN acquiring @SmallPharma $DMTTF. Agree or disagree Agree Disagree Agree Disagree" [X Link](https://x.com/PsychedVantage/status/1706503679640326327) 2023-09-26T02:59Z [----] followers, [---] engagements "🧵 When speaking with VCs and angel investors we notice that these specific companies focused on drug development are what get these investors the most excited. [--]. @Delix_tx [--]. @GilgameshRX [--]. @BeckleyPsytech [--]. @TerranBio [--]. @psilera [--]. @MindstateDesign [--]. @Psylo_Bio" [X Link](https://x.com/PsychedInsights/status/1726985827128119679) 2023-11-21T15:28Z [---] followers, [----] engagements "8. @PangeaBotanica [--]. Onsero [--]. @FreedomBioInc Worth mentioning: Many of these same investors are also very excited about @AltoNeuro (precision psychiatry) and @BlackrockNeuro_ (BCI)" [X Link](https://x.com/PsychedInsights/status/1726985829292364213) 2023-11-21T15:28Z [---] followers, [---] engagements "@MedicalGoldCa "Another issue is the actual launch of a product. MAPS MDMA therapy is finding stiff competition from J&Js (NYSE: JNJ) Spravato which has been a big hit and is already available to patients." Spravato is for TRD MDMA is for PTSD. Two different indications" [X Link](https://x.com/PsychedInsights/status/1727063171310186637) 2023-11-21T20:35Z [---] followers, [---] engagements "Results were absolutely incredible. Results half as good in terms of MADRS score reduction and remission rates in larger trials would still be mind blowing" [X Link](https://x.com/PsychedInsights/status/1730585203863663080) 2023-12-01T13:50Z [---] followers, [---] engagements ""Transcend's MDMA analog treatment showed rapid and persistent reduction in a small cohort of patients with severe PTSD according to data presented late Tuesday afternoon. The drug Methylone is a chemical analog of MDMA" [X Link](https://x.com/PsychedInsights/status/1732177783177023826) 2023-12-05T23:19Z [---] followers, [---] engagements "the more widely-known psychedelic treatment that is soon to reach the FDAs desk to treat PTSD. Methylone is not a hallucinogen but is psychoactive similar to Johnson & Johnsons esketamine drug Spravato."" [X Link](https://x.com/PsychedInsights/status/1732177784435253395) 2023-12-05T23:19Z [---] followers, [--] engagements "2 publicly traded companies we see potentially getting acquired or partnering with large pharma for certain programs: [--]. @brightmindsbio $DRUG [--]. @BetterLifeBio $BETRF" [X Link](https://x.com/PsychedVantage/status/1733904462748553564) 2023-12-10T17:40Z [----] followers, [---] engagements "is anticipated to be released before year end. According to leadership at Compass speaking at the 6th Annual Evercore ISI HealthCONx Conference: Top-line safety data from the trial is expected to be shared by year end with efficacy data coming in 2024" [X Link](https://x.com/PsychedInsights/status/1735893356058706228) 2023-12-16T05:23Z [---] followers, [---] engagements "Both companies have seen the share price of their stocks run up into these results. (Potentially due to @maps_pbc filing their NDA for MDMA-assisted therapy). With all this being said We at Psychedelic Insights wish everyone happy holidays. We are grateful for all of you" [X Link](https://x.com/PsychedInsights/status/1735893358202016028) 2023-12-16T05:23Z [---] followers, [---] engagements "Citadel Advisors LLC has increased their stake in $CMPS. More institutional money coming into the space. On November 14th they reported owning [-------] shares of the company. They own [-------] shares as of December 20th" [X Link](https://x.com/PsychedInsights/status/1742299874341585107) 2024-01-02T21:40Z [---] followers, [---] engagements "@mycopreneur I understand this viewpoint for sure and could discuss this point specifically more. Investing/money aside though I think its pretty reasonable to discuss importance of therapy component of PAT when dealing with people struggling with mental health immensely" [X Link](https://x.com/PsychedInsights/status/1742337213180867037) 2024-01-03T00:08Z [---] followers, [--] engagements "🧵 Announcement: I made a mistake in my reporting of Citadel and Paradigm increasing their stake in $CMPS: From SEC filing in the case with Citadel for example: [--] The percentages reported in this Schedule 13G are based upon [--------] Shares outstanding comprised of (i)" [X Link](https://x.com/anyuser/status/1742428497568551089) 2024-01-03T06:11Z [--] followers, [----] engagements "🧵 The mental health crisis will be even more of a problem in the coming years unfortunately. When you go out to a nice restaurant and see a [--] year old on their iPad at a family dinner completely disconnected from reality kids having access to online pornography young people spending less and less time socializing the list goes on and on and on. this is literally a black mirror episode this is literally a black mirror episode" [X Link](https://x.com/anyuser/status/1742618918328377537) 2024-01-03T18:48Z [--] followers, [---] engagements "Yeah how dare MAPS try to put emphasis on treating people who have risked their lives to protect our country with a therapy that has been shown in two phase [--] trials to keep 70% of people with treatment resistant PTSD in remission one year after therapy. (Sarcasm). Unsurprising that maps reveals their PBC to be a military specific counseling center The website is giving ROTC recruitment 🤮 Unsurprising that maps reveals their PBC to be a military specific counseling center The website is giving ROTC recruitment 🤮" [X Link](https://x.com/anyuser/status/1743292606925201414) 2024-01-05T15:25Z [--] followers, [----] engagements "But MDMA-assisted psychotherapy with licensed mental health professionals is not available for those with PTSD. I support both the recreational and medical model but there is and needs to be a distinction. IMO -Jake @PaulAustin3w Do these people not know that MDMA is readily available in hundreds of cities around the planet right now @PaulAustin3w Do these people not know that MDMA is readily available in hundreds of cities around the planet right now" [X Link](https://x.com/PsychedVantage/status/1743414510264668395) 2024-01-05T23:29Z [---] followers, [--] engagements "But MDMA-assisted psychotherapy with licensed mental health professionals is not available for those with PTSD. And I hope this changes. -Jake @PaulAustin3w Do these people not know that MDMA is readily available in hundreds of cities around the planet right now @PaulAustin3w Do these people not know that MDMA is readily available in hundreds of cities around the planet right now" [X Link](https://x.com/anyuser/status/1743416418131931372) 2024-01-05T23:37Z [--] followers, [---] engagements "@douchante @atai_life To start are you a licensed mental health professional -Jake" [X Link](https://x.com/anyuser/status/1743653246663581743) 2024-01-06T15:18Z [--] followers, [--] engagements "@douchante @atai_life If not my personal opinion would be to go into Psychology/Social Work or another field related to mental health. I myself am in school for social work and hope one day I can receive this training. -Jake" [X Link](https://x.com/PsychedVantage/status/1743654298184020406) 2024-01-06T15:22Z [---] followers, [--] engagements "@KingFranklinIV @BrianBarnettMD @AbstractIdea12 How would offering psychedelic therapy to those with TRD/PTSD for example with licensed mental health professionals work out without the medical system -Jake" [X Link](https://x.com/anyuser/status/1743704068315291895) 2024-01-06T18:40Z [--] followers, [--] engagements "Also as a psychiatrist surely you believe in the importance of being educated on mental health disorders. Not saying you HAVE to be licensed to be good at helping those navigate these experiences. However when it comes to working with vulnerable patient populations specifically surely there is a lot of value in being a licensed mental health professional. -Jake" [X Link](https://x.com/PsychedVantage/status/1743704934271287442) 2024-01-06T18:43Z [---] followers, [--] engagements "@junglejava1 Happy birthday" [X Link](https://x.com/anyuser/status/1744174485731688729) 2024-01-08T01:49Z [--] followers, [--] engagements "@ysl_mask @cburniske I have no knowledge on crypto. Any value with Bitcoin besides from being what the next person is willing to pay for it -Jake" [X Link](https://x.com/PsychedVantage/status/1744412740888752489) 2024-01-08T17:36Z [---] followers, [--] engagements "The nature of drug development companies sometimes unfortunately. Not everyone can stomach the swings in biotech. Much of stock declining was macro/one of worst biotech bear markets ever and out of their control. Personally I could not be happier with how they have decided to use their cash and snipe opportunities with a company I view as being ridiculously undervalued. [--] million to buy 35.5% of Beckley was a steal in my opinion and an absolutely brilliant investment. In short term they now have three phase [--] readouts in [----] and one in phase [--]. And this is through their strategic" [X Link](https://x.com/PsychedInsights/status/1744491875652841654) 2024-01-08T22:50Z [---] followers, [--] engagements "@PierceARK I know you are excited about the potential of Psilocybin as am I. Keep an eye on these phase [--] readouts looking at 5-MeO-DMT coming this year. -Jake" [X Link](https://x.com/anyuser/status/1744737839768863010) 2024-01-09T15:08Z [--] followers, [--] engagements "It is no secret that [----] has the potential to be a truly transformative year for the psychedelic medicine space. In preparation we have decided to step things up. We are now Psychedelic Vantage @PsychedVantage. We cannot wait to continue putting out more content this year. We will also be sharing our new website soon filled with articles on the psychedelic medicine investment space and more. Stay tuned" [X Link](https://x.com/anyuser/status/1747380265016578429) 2024-01-16T22:08Z [--] followers, [----] engagements "Very big year for the company and the entire sector. I am keeping my eye on FDAs response to Lykos Therapeutics request to give priority review to MDMA-assisted Therapy. This would mean approval decision would take [--] months instead of [--] months. Then you have many company specific potential catalysts for $ATAI this year. Assuming the readouts from Beckley and Compass are good combined with an improving macro outlook for the market could be a big time year indeed. -Jake" [X Link](https://x.com/PsychedVantage/status/1749568384545562641) 2024-01-22T23:03Z [---] followers, [--] engagements "*5-MeO-DMT is the most powerful. DMT is the most powerful psychedelic in the world. It's naturally produced by the human body. It is fully metabolized in 15-30 minutes. It's in hundreds of plants & fungi spread around the world. No other psychedelic has these properties. Why is DMT everywhere DMT is the most powerful psychedelic in the world. It's naturally produced by the human body. It is fully metabolized in 15-30 minutes. It's in hundreds of plants & fungi spread around the world. No other psychedelic has these properties. Why is DMT everywhere" [X Link](https://x.com/PsychedInsights/status/1750922280266236307) 2024-01-26T16:42Z [---] followers, [---] engagements "Psychedelics combined with psychological support show best results in terms of anti-depressant effects when the person tripping" [X Link](https://x.com/anyuser/status/1751046235719344437) 2024-01-27T00:55Z [--] followers, [---] engagements "Red Light Holland: Nourishing Minds From Meals to Mental Health @redlightholland $TRUFF $TRIP by @Waracken https://psychedelicvantage.com/2024/01/26/red-light-holland-nourishing-minds-from-meals-to-mental-health/ https://psychedelicvantage.com/2024/01/26/red-light-holland-nourishing-minds-from-meals-to-mental-health/" [X Link](https://x.com/PsychedVantage/status/1751538932154577381) 2024-01-28T09:33Z [---] followers, [---] engagements "Best YouTube channel about mental health and medication by a long shot. Stuck in the anxiety treatment dilemma 🔄😧 My latest video cuts through confusion comparing psychotherapy and medication and guiding you towards peace of mind 🧠 https://t.co/9ah6XevdF0 Stuck in the anxiety treatment dilemma 🔄😧 My latest video cuts through confusion comparing psychotherapy and medication and guiding you towards peace of mind 🧠 https://t.co/9ah6XevdF0" [X Link](https://x.com/PsychedVantage/status/1752106675585069430) 2024-01-29T23:09Z [---] followers, [---] engagements "@BioStockAnalyst @EliLillyandCo invested in the Series C. -Jake" [X Link](https://x.com/PsychedVantage/status/1753418412661826021) 2024-02-02T14:01Z [---] followers, [---] engagements "FDA approval for MDMA is going to happen this week. r/pennystocks Note: The FDA MAY accept the NDA and MAY give MDMA-assisted therapy priority review. In this case we would get an approval decision from the FDA most likely in [--] months time instead of [--] months" [X Link](https://x.com/PsychedVantage/status/1754324253455839269) 2024-02-05T02:01Z [---] followers, [----] engagements "Awakn Life Sciences Announces Listing on the Canadian Securities Exchange $AWKN $AWKNF https://www.newsfilecorp.com/release/197585/Awakn-Life-Sciences-Announces-Listing-on-the-Canadian-Securities-Exchange https://www.newsfilecorp.com/release/197585/Awakn-Life-Sciences-Announces-Listing-on-the-Canadian-Securities-Exchange" [X Link](https://x.com/PsychedVantage/status/1757080147654770891) 2024-02-12T16:32Z [----] followers, [---] engagements "Tryp Therapeutics to Tryptamine Therapeutics Australia Limited by: @Waracken $TRYP $TRYPF @TrypTherapeutic Brief breakdown discussing the information circular released for Tryp's Shareholder meeting https://psychedelicvantage.com/2024/02/15/tryp-therapeutics-to-tryptamine-therapeutics-australia-limited/ https://psychedelicvantage.com/2024/02/15/tryp-therapeutics-to-tryptamine-therapeutics-australia-limited/ https://psychedelicvantage.com/2024/02/15/tryp-therapeutics-to-tryptamine-therapeutics-australia-limited/" [X Link](https://x.com/PsychedVantage/status/1758145186981421396) 2024-02-15T15:04Z [----] followers, [----] engagements "I think a lot of work is being done on the non-hallucinogenic side of all of this for neurodegenerative diseases. Excited to eventually see data from Compass looking at autism spectrum disoder/ Mindmed looking at R-MDMA for social anxiety in autism spectrum disorder. So much exciting research going on" [X Link](https://x.com/PsychedVantage/status/1759008468290109521) 2024-02-18T00:14Z [---] followers, [---] engagements "News: @ClearmindCMND receives Patent Approval in China for treatment of binge behaviors $CMND Full Release:" [X Link](https://x.com/PsychedVantage/status/1762147327190433831) 2024-02-26T16:07Z [---] followers, [---] engagements "Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement $MNMD https://www.businesswire.com/news/home/20240307267521/en/Mind-Medicine-MindMed-Inc.-Announces-Pricing-of-Underwritten-Offering-of-Common-Shares-and-Concurrent-Private-Placement https://www.businesswire.com/news/home/20240307267521/en/Mind-Medicine-MindMed-Inc.-Announces-Pricing-of-Underwritten-Offering-of-Common-Shares-and-Concurrent-Private-Placement" [X Link](https://x.com/PsychedVantage/status/1765714439515377827) 2024-03-07T12:21Z [---] followers, [---] engagements "Mindmed $MNMD LSDs Future in Psychiatry https://youtu.be/L2pv_2eLZ6Esi=-uSdwg7Ng_fsx4O4 https://youtu.be/L2pv_2eLZ6Esi=-uSdwg7Ng_fsx4O4" [X Link](https://x.com/PsychedVantage/status/1767344453436555493) 2024-03-12T00:18Z [---] followers, [----] engagements "Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry $CYBN https://ir.cybin.com/investors/news/news-details/2024/Cybin-Announces-Publication-of-Research-Manuscript-in-the-Journal-of-Medicinal-Chemistry/default.aspx https://ir.cybin.com/investors/news/news-details/2024/Cybin-Announces-Publication-of-Research-Manuscript-in-the-Journal-of-Medicinal-Chemistry/default.aspx" [X Link](https://x.com/PsychedVantage/status/1780922468233777412) 2024-04-18T11:32Z [---] followers, [---] engagements "Tryp Therapeutics Provides Update on Plan of Arrangement With Exopharm Limited and Announces Voluntary Trading Halt $TRYPF https://www.accesswire.com/855838/tryp-therapeutics-provides-update-on-plan-of-arrangement-with-exopharm-limited-and-announces-voluntary-trading-halt https://www.accesswire.com/855838/tryp-therapeutics-provides-update-on-plan-of-arrangement-with-exopharm-limited-and-announces-voluntary-trading-halt" [X Link](https://x.com/PsychedVantage/status/1783121871556243641) 2024-04-24T13:12Z [----] followers, [---] engagements "MindMed to Present at Upcoming May Medical Conferences $MNMD https://www.businesswire.com/news/home/20240425701302/en/MindMed-to-Present-at-Upcoming-May-Medical-Conferences https://www.businesswire.com/news/home/20240425701302/en/MindMed-to-Present-at-Upcoming-May-Medical-Conferences" [X Link](https://x.com/PsychedVantage/status/1783452623888109702) 2024-04-25T11:06Z [---] followers, [---] engagements "Tryp Therapeutics and Exopharm Limited Announce Completion of Plan of Arrangement $TRYPF https://www.accesswire.com/858639/tryp-therapeutics-and-exopharm-limited-announce-completion-of-plan-of-arrangement https://www.accesswire.com/858639/tryp-therapeutics-and-exopharm-limited-announce-completion-of-plan-of-arrangement" [X Link](https://x.com/PsychedVantage/status/1785769642792779912) 2024-05-01T20:33Z [----] followers, [---] engagements "Reunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo Holdings https://finance.yahoo.com/news/reunion-neuroscience-inc-announces-103-103000336.html https://finance.yahoo.com/news/reunion-neuroscience-inc-announces-103-103000336.html" [X Link](https://x.com/PsychedVantage/status/1785986301012947293) 2024-05-02T10:54Z [---] followers, [---] engagements "MindMed to Host Conference Call and Webcast to Discuss First Quarter [----] Financial Results and Provide Business Update $MNMD https://www.businesswire.com/news/home/20240502898236/en/MindMed-to-Host-Conference-Call-and-Webcast-to-Discuss-First-Quarter-2024-Financial-Results-and-Provide-Business-Update https://www.businesswire.com/news/home/20240502898236/en/MindMed-to-Host-Conference-Call-and-Webcast-to-Discuss-First-Quarter-2024-Financial-Results-and-Provide-Business-Update" [X Link](https://x.com/PsychedVantage/status/1785991099661570454) 2024-05-02T11:13Z [---] followers, [---] engagements "If you follow the content that we put out on the Psychedelic Vantage YouTube channel then you will know that we have been very excited about the potential of short acting psychedelics for quite some time. We became even more optimistic about the potential of short acting psychedelics for a range of psychiatric indications when in [----] Small Pharma released phase 2a data showing that SPL026 (IV-administered NN-DMT) displayed rapid acting and durable anti-depressant effects in MDD. Many are now beginning to believe that the intensity of the psychedelic experience may be more important than the" [X Link](https://x.com/PsychedVantage/status/1788016645656436902) 2024-05-08T01:22Z [----] followers, [---] engagements "Abbreviations: MDD (major depressive disorder) GAD (generalized anxiety disorder) OCD (obsessive compulsive disorder) TRD (treatment resistant depression) AUD (alcohol use disorder)" [X Link](https://x.com/PsychedVantage/status/1788045910062010444) 2024-05-08T03:18Z [---] followers, [---] engagements "MindMed Reports First Quarter [----] Financial Results and Business Updates $MNMD https://ir.mindmed.co/news-events/press-releases/detail/145/mindmed-reports-first-quarter-2024-financial-results-and-business-updates https://ir.mindmed.co/news-events/press-releases/detail/145/mindmed-reports-first-quarter-2024-financial-results-and-business-updates" [X Link](https://x.com/PsychedVantage/status/1788299095926284378) 2024-05-08T20:05Z [---] followers, [---] engagements "AbbVie and @GilgameshRX Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders https://www.prnewswire.com/news-releases/abbvie-and-gilgamesh-pharmaceuticals-announce-collaboration-and-option-to-license-agreement-to-develop-next-generation-therapies-for-psychiatric-disorders-302143485.html https://www.prnewswire.com/news-releases/abbvie-and-gilgamesh-pharmaceuticals-announce-collaboration-and-option-to-license-agreement-to-develop-next-generation-therapies-for-psychiatric-disorders-302143485.html" [X Link](https://x.com/PsychedVantage/status/1790008856765944016) 2024-05-13T13:19Z [---] followers, [---] engagements "Skipping the Trip @abbvie x @GilgameshRX : The Epic of Gilgamesh Continued https://www.youtube.com/watchv=R98gJoO00-U https://www.youtube.com/watchv=R98gJoO00-U" [X Link](https://x.com/PsychedVantage/status/1792958885479039330) 2024-05-21T16:41Z [---] followers, [---] engagements "Cybin Appoints Dr. Atul Mahableshwarkar M.D. as Senior Vice President Clinical Development $CYBN https://ir.cybin.com/investors/news/news-details/2024/Cybin-Appoints-Dr.-Atul-Mahableshwarkar-M.D.-as-Senior-Vice-President-Clinical-Development/default.aspx https://ir.cybin.com/investors/news/news-details/2024/Cybin-Appoints-Dr.-Atul-Mahableshwarkar-M.D.-as-Senior-Vice-President-Clinical-Development/default.aspx" [X Link](https://x.com/PsychedVantage/status/1800491138559938707) 2024-06-11T11:31Z [---] followers, [---] engagements "MindMed Announces Constructive End-of-Phase [--] Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD) $MNMD https://www.businesswire.com/news/home/20240620626324/en/MindMed-Announces-Constructive-End-of-Phase-2-Meeting-with-U.S.-FDA-for-MM120-in-Generalized-Anxiety-Disorder-GAD https://www.businesswire.com/news/home/20240620626324/en/MindMed-Announces-Constructive-End-of-Phase-2-Meeting-with-U.S.-FDA-for-MM120-in-Generalized-Anxiety-Disorder-GAD" [X Link](https://x.com/PsychedVantage/status/1803761258245545991) 2024-06-20T12:06Z [---] followers, [---] engagements "MindMed to be Included in Russell [----] and Russell [----] Indexes $MNMD https://finance.yahoo.com/news/mindmed-included-russell-2000-russell-110000072.html https://finance.yahoo.com/news/mindmed-included-russell-2000-russell-110000072.html" [X Link](https://x.com/PsychedVantage/status/1806653288521085053) 2024-06-28T11:38Z [---] followers, [---] engagements "Amazing write up here by @PeterKolchinsky and Sarah Reed from RA Captial. RA Captial is currently invested in $GHRS $CYBN and $CMPS. They also invested in Delix Therapeutics Series A financing round in [----]. As of our knowledge they were one of the first blue chip life sciences investment firms to put money into psychedelic drug development. https://rapport.bio/all-stories/obvious-in-hindsight-financings-pricing-uncertainty-early-access https://rapport.bio/all-stories/obvious-in-hindsight-financings-pricing-uncertainty-early-access" [X Link](https://x.com/PsychedVantage/status/1812710440537117142) 2024-07-15T04:47Z [---] followers, [----] engagements "MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT) $MNMD https://finance.yahoo.com/news/mindmed-announces-issuance-patent-mm120-110000178.html https://finance.yahoo.com/news/mindmed-announces-issuance-patent-mm120-110000178.html" [X Link](https://x.com/PsychedVantage/status/1813534016454463733) 2024-07-17T11:19Z [---] followers, [---] engagements "IntelGenx Provides Update on Previously Announced Sale and Investment Solicitation Process As Phase [--] of the SISP did not result in alternative superior bids IntelGenx and atai Life Sciences AG (atai) have now initiated the process to complete the purchase and sale transaction. The parties currently expect to obtain final approval from the Qubec Superior Court (Commercial Division) and close the transaction prior to September [--] [----]. $ATAI" [X Link](https://x.com/PsychedVantage/status/1814430316133527999) 2024-07-19T22:41Z [---] followers, [---] engagements "MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer $MNMD https://www.businesswire.com/news/home/20240729857388/en/ https://www.businesswire.com/news/home/20240729857388/en/" [X Link](https://x.com/PsychedVantage/status/1817894069722370383) 2024-07-29T12:04Z [---] followers, [---] engagements "@Josh__Hardman Mindmed and Cybin raises were timely. -Jake" [X Link](https://x.com/PsychedVantage/status/1820546717554823578) 2024-08-05T19:45Z [---] followers, [---] engagements "MindMed to Host Conference Call and Webcast to Discuss Second Quarter [----] Financial Results and Provide Business Update $MNMD https://ir.mindmed.co/news-events/press-releases/detail/154/mindmed-to-host-conference-call-and-webcast-to-discuss-second-quarter-2024-financial-results-and-provide-business-update https://ir.mindmed.co/news-events/press-releases/detail/154/mindmed-to-host-conference-call-and-webcast-to-discuss-second-quarter-2024-financial-results-and-provide-business-update" [X Link](https://x.com/PsychedVantage/status/1820802827926609975) 2024-08-06T12:43Z [---] followers, [---] engagements "Mind Medicine (MindMed) Inc. Announces Proposed Public Offering $MNMD https://www.businesswire.com/news/home/20240808999979/en/Mind-Medicine-MindMed-Inc.-Announces-Proposed-Public-Offering https://www.businesswire.com/news/home/20240808999979/en/Mind-Medicine-MindMed-Inc.-Announces-Proposed-Public-Offering" [X Link](https://x.com/PsychedVantage/status/1821860828288602291) 2024-08-09T10:47Z [---] followers, [---] engagements "atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT) $ATAI https://finance.yahoo.com/news/atai-life-sciences-announces-positive-110000472.html https://finance.yahoo.com/news/atai-life-sciences-announces-positive-110000472.html" [X Link](https://x.com/PsychedVantage/status/1823317872472416542) 2024-08-13T11:17Z [----] followers, [---] engagements "MindMed Reports Second Quarter [----] Financial Results and Business Updates $MNMD https://finance.yahoo.com/news/mindmed-reports-second-quarter-2024-110000016.html https://finance.yahoo.com/news/mindmed-reports-second-quarter-2024-110000016.html" [X Link](https://x.com/PsychedVantage/status/1823322824003469427) 2024-08-13T11:36Z [---] followers, [---] engagements "@RCarhartHarris @drmikehart @TheBorisLab @dr_brein @joerogan @hubermanlab @TheoVon @Drug_Researcher There is also open label data from Compass n=20 Mindmed ran a study a while back and Cybin had great phase 2a data looking at their psilocybin analog as an adjunct treatment. More data needed of course. But looks good so far. -Jake" [X Link](https://x.com/PsychedVantage/status/1826664833619546170) 2024-08-22T16:56Z [---] followers, [---] engagements "White House announces rule that would cut insurance red tape over mental health and substance use disorder care https://www.google.com/urlq=https://www.cnn.com/2024/09/09/health/mental-health-parity-rule/index.html&source=gmail&ust=1725975788289000&usg=AOvVaw3tVapYr6HvsKUAocgadLRN&rct=i https://www.google.com/urlq=https://www.cnn.com/2024/09/09/health/mental-health-parity-rule/index.html&source=gmail&ust=1725975788289000&usg=AOvVaw3tVapYr6HvsKUAocgadLRN&rct=i" [X Link](https://x.com/PsychedVantage/status/1833139889312866535) 2024-09-09T13:46Z [----] followers, [----] engagements "@CulperResearch Did you guys cover your short position on $AXSM yet -Jake" [X Link](https://x.com/PsychedVantage/status/1836774891296567673) 2024-09-19T14:30Z [----] followers, [----] engagements "The purpose of this study is to determine the safety and feasibility of sequencing psilocybin therapy with a short-duration aiTBS protocol (Stanford Accelerated Intelligent Neuromodulation Therapy or SAINT) in individuals with treatment-resistant major depressive disorder. is great http://Clinicaltrials.gov https://clinicaltrials.gov/study/NCT06132178intr=COMP360&rank=7 https://clinicaltrials.gov/study/NCT06132178intr=COMP360&rank=7 http://Clinicaltrials.gov https://clinicaltrials.gov/study/NCT06132178intr=COMP360&rank=7 https://clinicaltrials.gov/study/NCT06132178intr=COMP360&rank=7" [X Link](https://x.com/PsychedVantage/status/1837157067498426683) 2024-09-20T15:49Z [----] followers, [---] engagements "Psychedelic Drug Development: What We Are Looking Out For $CMPS $MNMD $GHRS $ATAI $CYBN https://www.youtube.com/watchv=o7-4PML6K9M https://www.youtube.com/watchv=o7-4PML6K9M" [X Link](https://x.com/PsychedVantage/status/1839720261857489305) 2024-09-27T17:34Z [----] followers, [---] engagements "One prediction is already starting to come into play as $ATAI has begun selling their stake in $CMPS. Check out our new video where we touched on this: https://youtu.be/o7-4PML6K9Msi=pLHBd2Z5GhcshTCJ https://atai.gcs-web.com/node/8646/html What I will be watching out for in the next 4-8 months/predictions. I reserve the right to be wrong about predictions. None of this is financial advice. -Jake $CYBN will become first company in the space to receive FDA breakthrough therapy designation for two different programs. https://youtu.be/o7-4PML6K9Msi=pLHBd2Z5GhcshTCJ" [X Link](https://x.com/PsychedVantage/status/1839822861420183700) 2024-09-28T00:22Z [----] followers, [----] engagements "IntelGenx is Granted Court Approval of the Sale Proposal from atai Life Sciences AG $ATAI https://www.globenewswire.com/news-release/2024/10/02/2957030/0/en/IntelGenx-is-Granted-Court-Approval-of-the-Sale-Proposal-from-atai-Life-Sciences-AG.html https://www.globenewswire.com/news-release/2024/10/02/2957030/0/en/IntelGenx-is-Granted-Court-Approval-of-the-Sale-Proposal-from-atai-Life-Sciences-AG.html" [X Link](https://x.com/PsychedVantage/status/1841514890688668100) 2024-10-02T16:25Z [----] followers, [---] engagements "Up 450% today so far. This is why you set alerts when you hold individual stocks. No one at Psychedelic Vantage is currently holding $DRUG. None of this is financial advice. $DRUG also working with 5-HT2C agonists currently up 43% off this news. $DRUG also working with 5-HT2C agonists currently up 43% off this news" [X Link](https://x.com/PsychedVantage/status/1846204219243520419) 2024-10-15T14:59Z [----] followers, [---] engagements "Discovery of novel 5-HT2A receptor agonists with non-hallucinogenic potential and translational antidepressant drug-like profiles $ATAI https://ir.atai.life/static-files/d48833a8-bf0c-4abd-b886-58d87d0c83d4 https://ir.atai.life/static-files/d48833a8-bf0c-4abd-b886-58d87d0c83d4" [X Link](https://x.com/PsychedVantage/status/1846605940264432002) 2024-10-16T17:35Z [----] followers, [---] engagements "@NotGonnaNotGon Would you consider this engagement on high doses of classical psychedelics to be psychotherapy -Jake" [X Link](https://x.com/PsychedVantage/status/1848707883099140114) 2024-10-22T12:48Z [----] followers, [---] engagements "Compass Pathways to Announce Third Quarter Financial Results on October [--] [----] $CMPS https://www.businesswire.com/news/home/20241024060255/en/Compass-Pathways-to-Announce-Third-Quarter-Financial-Results-on-October-31-2024 https://www.businesswire.com/news/home/20241024060255/en/Compass-Pathways-to-Announce-Third-Quarter-Financial-Results-on-October-31-2024" [X Link](https://x.com/PsychedVantage/status/1849406083854401619) 2024-10-24T11:02Z [----] followers, [---] engagements "MindMed to Host Conference Call and Webcast to Discuss Third Quarter [----] Financial Results and Provide Business Update $MNMD https://www.businesswire.com/news/home/20241024456529/en/MindMed-to-Host-Conference-Call-and-Webcast-to-Discuss-Third-Quarter-2024-Financial-Results-and-Provide-Business-Update https://www.businesswire.com/news/home/20241024456529/en/MindMed-to-Host-Conference-Call-and-Webcast-to-Discuss-Third-Quarter-2024-Financial-Results-and-Provide-Business-Update" [X Link](https://x.com/PsychedVantage/status/1849419839720374535) 2024-10-24T11:57Z [---] followers, [---] engagements "Compass Pathways' Updates First and Second Movers MindMed and Cybin Approaching Phase [--] $CMPS $MNMD $CYBN https://www.youtube.com/watchv=NlMtncyEau4 https://www.youtube.com/watchv=NlMtncyEau4" [X Link](https://x.com/PsychedVantage/status/1853181628312424786) 2024-11-03T21:05Z [---] followers, [----] engagements "MindMed Reports Third Quarter [----] Financial Results and Business Updates $MNMD https://www.businesswire.com/news/home/20241107702200/en/MindMed-Reports-Third-Quarter-2024-Financial-Results-and-Business-Updates https://www.businesswire.com/news/home/20241107702200/en/MindMed-Reports-Third-Quarter-2024-Financial-Results-and-Business-Updates" [X Link](https://x.com/PsychedVantage/status/1854631302252970416) 2024-11-07T21:05Z [---] followers, [---] engagements "A lot of posts about RFK Jr. with people tagging $CMPS $ATAI $CYBN $MNMD $GHRS I dont know about you folks but RFK Jr. doesnt exactly seem pro-pharma to me. Either way not sure how much say this guy will have in our public health policies. -Jake" [X Link](https://x.com/PsychedVantage/status/1855783947638096314) 2024-11-11T01:25Z [---] followers, [----] engagements "atai Life Sciences Reports Third Quarter [----] Financial Results and Provides Corporate Updates $ATAI https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-reports-third-quarter-2024-financial-results https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-reports-third-quarter-2024-financial-results" [X Link](https://x.com/PsychedVantage/status/1856684403226755301) 2024-11-13T13:03Z [---] followers, [---] engagements "MindMed Appoints Gregg Pratt Ph.D. as Chief Regulatory and Quality Assurance Officer $MNMD https://www.businesswire.com/news/home/20241118653031/en/MindMed-Appoints-Gregg-Pratt-Ph.D.-as-Chief-Regulatory-and-Quality-Assurance-Officer https://www.businesswire.com/news/home/20241118653031/en/MindMed-Appoints-Gregg-Pratt-Ph.D.-as-Chief-Regulatory-and-Quality-Assurance-Officer" [X Link](https://x.com/PsychedVantage/status/1858482331578679455) 2024-11-18T12:08Z [---] followers, [---] engagements "A must follow account Procrastination and ADHD A match made in heaven ❤. or hell 🔥 Isn't it just being lazy 🛋 Or is there something deeper at play 🤔 🧠 Dive in and find out whats really going on 👇🏽 https://t.co/zDnOQhK6nS Procrastination and ADHD A match made in heaven ❤. or hell 🔥 Isn't it just being lazy 🛋 Or is there something deeper at play 🤔 🧠 Dive in and find out whats really going on 👇🏽 https://t.co/zDnOQhK6nS" [X Link](https://x.com/PsychedVantage/status/1859704588049465690) 2024-11-21T21:05Z [---] followers, [---] engagements "Like what I am reading about Makary so far and what I am hearing from him in podcasts: - Recognizes we eat and drink poison in America ✅ - Acknowledges vaccines DO NOT cause Autism ✅ (seems to agree with RFK Jr. on food and not his other dangerous and debunked takes ✅) - Believes psychedelics have the potential to to treat mental health conditions and wants rigorous clinical trials to prove this ✅ Have a great weekend everyone. -Jake Biotech should rip higher Monday Biotech should rip higher Monday" [X Link](https://x.com/PsychedVantage/status/1860148372482425023) 2024-11-23T02:28Z [----] followers, [--] engagements "Really liking what Im reading and hearing about Dr. Marty Makary so far: Recognizes that we eat and drink poison in America ✅ Acknowledges that vaccines DO NOT cause autism ✅ Seems to align with RFK Jr. on the need for better food quality but not on his other dangerous and debunked takes ✅ Believes psychedelics have the potential to treat mental health conditions and advocates for rigorous clinical trials to prove this ✅ Have a great weekend everyone. -Jake Biotech should rip higher Monday Biotech should rip higher Monday" [X Link](https://x.com/PsychedVantage/status/1860149437190012967) 2024-11-23T02:32Z [----] followers, [----] engagements "New clinical trial registration: Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder $ATAI https://clinicaltrials.gov/study/NCT06693609intr=EMP-01&rank=1 https://clinicaltrials.gov/study/NCT06693609intr=EMP-01&rank=1" [X Link](https://x.com/PsychedVantage/status/1860718818185674934) 2024-11-24T16:15Z [---] followers, [---] engagements "List of clinical trial readouts anticipated in the coming months. As we all know these timelines can be subject to change: $ATAI Q4 2024: - ELE-101 phase 2a top-line open label data in MDD. N=6-12 trial participants with depression - BPL-003 phase 2a top-line open label data in AUD. N=13 Q2 2025: - BPL-003 phase 2b top-line data in TRD. N=185. According to November company presentation slide [--] ( Patients entering the open-label extension are randomized to receive either a single 12mg dose or a biphasic 4mg and 8mg dose approximately [--] minutes apart. Total N changed due to an adjustment in" [X Link](https://x.com/PsychedVantage/status/1860823834380939366) 2024-11-24T23:12Z [---] followers, [---] engagements "MindMed Appoints Javier Muniz M.D. as Vice President of Research and Development Strategy $MNMD https://www.biospace.com/press-releases/mindmed-appoints-javier-muniz-m-d-as-vice-president-of-research-and-development-strategy https://www.biospace.com/press-releases/mindmed-appoints-javier-muniz-m-d-as-vice-president-of-research-and-development-strategy" [X Link](https://x.com/PsychedVantage/status/1863939042728890660) 2024-12-03T13:31Z [---] followers, [---] engagements "MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD) $MNMD https://www.businesswire.com/news/home/20241205425128/en/MindMed-Awarded-Innovation-Passport-Designation-by-the-United-Kingdom-UK-Innovative-Licensing-and-Access-Pathway-ILAP-Steering-Group-for-MM120-Orally-Disintegrating-Tablet-ODT-for-Generalized-Anxiety-Disorder-GAD" [X Link](https://x.com/PsychedVantage/status/1864642062693359775) 2024-12-05T12:04Z [---] followers, [---] engagements "Cybins Corporate Presentation December [----] $CYBN https://s28.q4cdn.com/259445127/files/CYBN-Corporate-Deck-December-2024-Website-Final.pdf https://s28.q4cdn.com/259445127/files/CYBN-Corporate-Deck-December-2024-Website-Final.pdf" [X Link](https://x.com/PsychedVantage/status/1866587653459648980) 2024-12-10T20:55Z [---] followers, [---] engagements "MindMed Announces First Patient Dosed in Phase [--] Voyage Study of MM120 in Generalized Anxiety Disorder (GAD) $MNMD https://www.businesswire.com/news/home/20241216046321/en/ https://www.businesswire.com/news/home/20241216046321/en/" [X Link](https://x.com/PsychedVantage/status/1868640637157052456) 2024-12-16T12:53Z [---] followers, [---] engagements "Beckley Psytech announces positive topline results from Phase IIa study of ELE-101 (IV psilocin benzoate) for Major Depressive Disorder https://www.beckleypsytech.com/posts/beckley-psytech-announces-positive-topline-results-from-phase-iia-study-of-ele-101-for-major-depressive-disorder https://www.beckleypsytech.com/posts/beckley-psytech-announces-positive-topline-results-from-phase-iia-study-of-ele-101-for-major-depressive-disorder" [X Link](https://x.com/PsychedVantage/status/1868641673158566223) 2024-12-16T12:57Z [---] followers, [----] engagements "Awakn Life Sciences Enters into Binding Letter of Intent for Acquisition of Awakn by Graft Polymer (UK) Plc $AWKNF https://www.newsfilecorp.com/release/233897/Awakn-Life-Sciences-Enters-into-Binding-Letter-of-Intent-for-Acquisition-of-Awakn-by-Graft-Polymer-UK-Plc https://www.newsfilecorp.com/release/233897/Awakn-Life-Sciences-Enters-into-Binding-Letter-of-Intent-for-Acquisition-of-Awakn-by-Graft-Polymer-UK-Plc" [X Link](https://x.com/PsychedVantage/status/1868679105782469114) 2024-12-16T15:26Z [----] followers, [---] engagements "MindMeds Corporate Presentation-December 2024: $MNMD https://d1io3yog0oux5.cloudfront.net/_25951dd8646049733b7a9ba6d9a4c850/mindmed/db/2265/21500/pdf/MindMed+Investor+Presentation+December+2024+.pdf https://d1io3yog0oux5.cloudfront.net/_25951dd8646049733b7a9ba6d9a4c850/mindmed/db/2265/21500/pdf/MindMed+Investor+Presentation+December+2024+.pdf" [X Link](https://x.com/PsychedVantage/status/1869467369858593026) 2024-12-18T19:38Z [---] followers, [---] engagements "MindMed to Be Added to the Nasdaq Biotechnology Index $MNMD https://www.businesswire.com/news/home/20241219955108/en/MindMed-to-Be-Added-to-the-Nasdaq-Biotechnology-Index https://www.businesswire.com/news/home/20241219955108/en/MindMed-to-Be-Added-to-the-Nasdaq-Biotechnology-Index" [X Link](https://x.com/PsychedVantage/status/1869724720469618805) 2024-12-19T12:41Z [---] followers, [---] engagements "@BiopharmIQ COMP360 data was pushed back to Q2 [----]. -Jake" [X Link](https://x.com/PsychedVantage/status/1871041544779964774) 2024-12-23T03:54Z [---] followers, [---] engagements "@psy_dao Looking forward to seeing the data Hopefully this data readout and the many others in the space across different compounds and indications in [----] will be positive. -Jake" [X Link](https://x.com/PsychedVantage/status/1873877092125073881) 2024-12-30T23:41Z [----] followers, [--] engagements "Hello Psychedelic Vantage community Jake here: After [--] months of believing that bi-phasic dosing was only recently introduced into the open label portion of Beckley Psytechs phase 2b trial it turns out that when $ATAIs original January [----] presentation came out showing Beckleys phase 2b trial design bi-phasic dosing was always part of the plan in the open label portion. I was able to find the January presentation online and as you will see bi-phasic dosing in open label portion of trial is mentioned in the footnotes on slide [--]. The only changes to the Beckley phase 2b trial since January is" [X Link](https://x.com/PsychedVantage/status/1873941236588929322) 2024-12-31T03:56Z [---] followers, [---] engagements "Happy new year everyone Who else is absolutely stoked for these big time clinical trial results in [----] (many were supposed to come in [----] but were pushed back) $GHRS phase 2b (Q1) $CYBN phase [--] (Q1) Reunion Neuroscience phase [--] readout in PPD Gilgamesh Pharmaceuticals with two phase 2s Beckley Psytech phase 2a in AUD phase 2b in TRD (Q2) $ATAI three phase [--] readouts Potential phase [--] readout from Transcend Therapeutics looking at Methylone in PTSD And of course $CMPS phase [--] (COMP005) (Q2) There may be other readouts but less clarity with guidance on some. For example $CMPS phase [--] in" [X Link](https://x.com/PsychedVantage/status/1874571818343727395) 2025-01-01T21:42Z [---] followers, [---] engagements "@BioTechTraderSD Or retail investors placing market orders instead of limit orders. I would know because when I first purchased this stock 2ish years ago and had not too much experience investing I sent the stock up 25% with a very small buy 😂. -Jake" [X Link](https://x.com/PsychedVantage/status/1874879408529699138) 2025-01-02T18:04Z [---] followers, [---] engagements "We cant forget the progress that has been made by $AXSM and $ITCI pretty recently. Great data from both companies. No space in depression research more important to watch than psychedelics/neuroplastogens especially for treatment resistant depression. Also excited about progress with SAINT TMS. -Jake I'm really bummed about $NMRA. I really want somebody to crack antidepresssants. I mean SSRIs are not great. It's so sad we can't do better. I'm really bummed about $NMRA. I really want somebody to crack antidepresssants. I mean SSRIs are not great. It's so sad we can't do better" [X Link](https://x.com/PsychedVantage/status/1874911518199873724) 2025-01-02T20:11Z [---] followers, [----] engagements "@BioTechTraderSD this is the first readout in the space in a long time where I feel that IF the data is positive (big what if of course) it wont sell off after at least not for a while. I could be wrong of course. Three reasons: [--]. Larger sample size than many readouts we have seen and it will be in TRD population. Historically it will be the 3rd largest after $MNMD and $CMPS. $MNMD data was spectacular but sold off later on (probably because MDMA was rejected) and $CMPS data didnt meet peoples expectations so the stock was shot down in late [----]. [--]. While phase 1/2a data for $GHRS was a" [X Link](https://x.com/PsychedVantage/status/1874988024410558615) 2025-01-03T01:15Z [---] followers, [---] engagements "I would like to defend MindMed here when it comes to psychotherapy outside of the clinical trial setting. My understanding is that in traditional anti-depressant drug trials participants can continue ongoing stable psychotherapy as long as it was established BEFORE the trial began and remains unchanged during the trial. -Jake I see your psychological support and I raise you - Mr. Mouse https://t.co/rtZQ9xvk5Z I see your psychological support and I raise you - Mr. Mouse https://t.co/rtZQ9xvk5Z" [X Link](https://x.com/PsychedVantage/status/1875705227560571096) 2025-01-05T00:45Z [---] followers, [---] engagements "atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health $ATAI https://www.globenewswire.com/news-release/2025/01/10/3007542/0/en/atai-Life-Sciences-Announces-Key-Leadership-Appointments-as-it-Advances-its-Pipeline-of-Novel-Psychedelic-Therapeutics-for-Mental-Health.html https://www.globenewswire.com/news-release/2025/01/10/3007542/0/en/atai-Life-Sciences-Announces-Key-Leadership-Appointments-as-it-Advances-its-Pipeline-of-Novel-Psychedelic-Therapeutics-for-Mental-Health.html" [X Link](https://x.com/PsychedVantage/status/1877689277238186050) 2025-01-10T12:09Z [---] followers, [---] engagements "Compass Pathways Announces Pricing of Underwritten Offering $CMPS https://ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-Announces-Pricing-of-Underwritten-Offering/default.aspx https://ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-Announces-Pricing-of-Underwritten-Offering/default.aspx" [X Link](https://x.com/PsychedVantage/status/1877689855569711561) 2025-01-10T12:12Z [---] followers, [---] engagements "According to what I have heard from $ATAI in other publicly available interviews: Since they are now operating less of a hub and spoke model and are focused a lot more on moving forward with their internal programs into later stages of development having Srini with his scientific background as CEO made sense. I really like the team at $ATAI. Honestly all big [--] publicly traded companies in this space have great teams. Night and day difference for many of them compared to when they first went public. -Jake" [X Link](https://x.com/PsychedVantage/status/1878207030088847550) 2025-01-11T22:27Z [---] followers, [---] engagements "@iamsigmaphi As an $ATAI shareholder I like it more than potentially getting diluted at these levels. I believe they still hold 10% of $CMPS despite $CMPS off their website. -Jake" [X Link](https://x.com/PsychedVantage/status/1878208953651167303) 2025-01-11T22:34Z [---] followers, [---] engagements "@iamsigmaphi I wonder when they start unloading more shares. Perhaps waiting for a run up in the $CMPS SP into phase [--] data. I would think they would spread out the sales. Will be interesting to follow. -Jake" [X Link](https://x.com/PsychedVantage/status/1878219259605590350) 2025-01-11T23:15Z [---] followers, [---] engagements "MindMeds Corporate Presentation January 2025: $MNMD https://d1io3yog0oux5.cloudfront.net/_80b2b065dd756bcc65a56ab23eb57ef8/mindmed/db/2265/21500/pdf/MindMed+January+2025+Corporate+Presentation.pdf https://d1io3yog0oux5.cloudfront.net/_80b2b065dd756bcc65a56ab23eb57ef8/mindmed/db/2265/21500/pdf/MindMed+January+2025+Corporate+Presentation.pdf" [X Link](https://x.com/PsychedVantage/status/1878921589665968443) 2025-01-13T21:46Z [---] followers, [---] engagements "7 months ago Kabir Nath (CEO of Compass Pathway) speaking about Big Pharmas lack of interest in late-stage first generation psychedelic drug development companies: $MNMD $GHRS $CMPS $ATAI $CYBN" [X Link](https://x.com/PsychedVantage/status/1878925669767491745) 2025-01-13T22:02Z [---] followers, [----] engagements "Let me state again: LEAST likely to be affected by overhyped RFK Jr. headlines (both to upside and downside) -Jake Stocks least likely to be affected by overhyped RFK Jr. headlines (both to upside and downside). I think there is only one correct answer here. Curious to see what this vote looks like. Comment if your answer is $MNMD: @elonmusk lets have the option for more choices in polls Stocks least likely to be affected by overhyped RFK Jr. headlines (both to upside and downside). I think there is only one correct answer here. Curious to see what this vote looks like. Comment if your answer" [X Link](https://x.com/PsychedVantage/status/1878941849265791485) 2025-01-13T23:07Z [---] followers, [---] engagements "@PsychedStocks @elonmusk When it comes to RFK Jr. headlines I 100% agree with you. Most upside with those names. Keep in mind poll was asking which stock would be LEAST affected. I am only mentioning this because I feel many misread the post based on the results of the poll so far lol. -Jake" [X Link](https://x.com/PsychedVantage/status/1878986244639883597) 2025-01-14T02:03Z [---] followers, [---] engagements "atai Life Sciences Company Presentation January 2025: $ATAI https://ir.atai.life/static-files/7d46c96f-e913-4dd8-bd34-6b39adef3a96 https://ir.atai.life/static-files/7d46c96f-e913-4dd8-bd34-6b39adef3a96" [X Link](https://x.com/PsychedVantage/status/1879074658450022722) 2025-01-14T07:54Z [---] followers, [----] engagements "Looked through all big [--] publicly traded psychedelic drug development company January presentations. Cybins most recent is from December. Only presentation I see noticeable changes in from previous presentations is from $ATAI. Seeing changes in atais company presentations from month to month has been a trend for $ATAI since they have been a public company for a variety of reasons. (Still big $ATAI bull I hold shares only company I have never moved out of since [----] (I averaged down quite a bit) but I feel the need to point this out)). What I notice: - Company states they have [--] clinical stage" [X Link](https://x.com/PsychedVantage/status/1879087552080248995) 2025-01-14T08:45Z [---] followers, [----] engagements "@imafordmustang You know I was really confident in $GHRS being the least likely to he affected positively or negatively by RFK Jr. headlines but when I think a bit more I can see $CMPS as the answer making sense. Curious to hear why $CMPS is your answer. -Jake" [X Link](https://x.com/PsychedVantage/status/1879091311065940104) 2025-01-14T09:00Z [---] followers, [---] engagements "@shroomgirl42 @imafordmustang You could be right about $CMPS I am not sure. They also just had a pretty brutal raise. I think $ATAI just needs the money. -Jake" [X Link](https://x.com/PsychedVantage/status/1879176042080092482) 2025-01-14T14:37Z [---] followers, [---] engagements "While not a change in $GHRS most recent presentation (previous one also showed this) it seems GH-003 (Intranasal 5-MeO-DMT) has been shelved. Forgot to mention this. Along with other changes to pipeline/plans of big [--] $CYBN CYB005 pre-clinical studies completion pushed back to [----]. Previous guidance (deep in SEC filings) stated completion in [----]. -Jake Looked through all big [--] publicly traded psychedelic drug development company January presentations. Cybins most recent is from December. Only presentation I see noticeable changes in from previous presentations is from $ATAI. Seeing changes" [X Link](https://x.com/PsychedVantage/status/1879258857610125651) 2025-01-14T20:06Z [---] followers, [---] engagements "Deep Track Capital LP reporting ownership of [-------] shares in $CMPS Deep Track Capital was also the lead investor for recent financing rounds by $MNMD and $CYBN in [----] $CMPS https://d18rn0p25nwr6d.cloudfront.net/CIK-0001816590/2425ebc1-2c1b-4244-b193-046948b9d970.pdf https://d18rn0p25nwr6d.cloudfront.net/CIK-0001816590/2425ebc1-2c1b-4244-b193-046948b9d970.pdf" [X Link](https://x.com/PsychedVantage/status/1880363362191831310) 2025-01-17T21:15Z [---] followers, [---] engagements "SPRAVATO (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression $JNJ https://www.jnj.com/media-center/press-releases/spravato-esketamine-approved-in-the-u-s-as-the-first-and-only-monotherapy-for-adults-with-treatment-resistant-depression https://www.jnj.com/media-center/press-releases/spravato-esketamine-approved-in-the-u-s-as-the-first-and-only-monotherapy-for-adults-with-treatment-resistant-depression" [X Link](https://x.com/PsychedVantage/status/1881728795780284564) 2025-01-21T15:41Z [---] followers, [----] engagements "Awakn Announces Positive Outcome of Pre-IND Meeting with FDA for AWKN-002 in Alcohol Use Disorder $AWKNF https://awaknlifesciences.com/awkn-002-pre-ind-fda https://awaknlifesciences.com/awkn-002-pre-ind-fda" [X Link](https://x.com/PsychedVantage/status/1881757057176723712) 2025-01-21T17:33Z [----] followers, [---] engagements "What are you most looking forward to seeing in the coming weeks and months Comment below why you chose your answer $MNMD $GHRS $CMPS $ATAI $CYBN RFK Jr. news Clinical trial data RFK Jr. news Clinical trial data" [X Link](https://x.com/PsychedVantage/status/1882155425463967818) 2025-01-22T19:56Z [---] followers, [----] engagements "Upcoming milestones $ATAI" [X Link](https://x.com/PsychedVantage/status/1883614210816651527) 2025-01-26T20:33Z [---] followers, [---] engagements "Is there a world where results of RFK Jr. senate vote is not a sell the news event Comment below with your thoughts. I am holding all of my shares in $ATAI and $GHRS through the RFK Jr. news either way (NOT financial advice just sharing what I am doing to be transparent along with avoiding accusations of causing FUD) -Jake $MNMD $CMPS $ATAI $CYBN Yes No Yes No" [X Link](https://x.com/PsychedVantage/status/1887276827330421098) 2025-02-05T23:07Z [---] followers, [---] engagements "atai Life Sciences Announces Proposed Public Offering of Common Shares $ATAI https://atai.gcs-web.com/news-releases/news-release-details/atai-life-sciences-announces-proposed-public-offering-common https://atai.gcs-web.com/news-releases/news-release-details/atai-life-sciences-announces-proposed-public-offering-common" [X Link](https://x.com/PsychedVantage/status/1889782568578429116) 2025-02-12T21:04Z [----] followers, [----] engagements "atai Life Sciences Announces First Patient Dosed in Elumina the Phase [--] Clinical Trial of VLS-01 for Treatment-Resistant Depression $ATAI https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-first-patient-dosed-elumina-phase-2 https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-first-patient-dosed-elumina-phase-2" [X Link](https://x.com/PsychedVantage/status/1899417361729339476) 2025-03-11T11:09Z [----] followers, [----] engagements "Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression $CMPS https://ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-Announces-Publication-of-Results-from-COMP004-Study-on-COMP360-Psilocybin-for-Treatment-Resistant-Depression/default.aspx https://ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-Announces-Publication-of-Results-from-COMP004-Study-on-COMP360-Psilocybin-for-Treatment-Resistant-Depression/default.aspx" [X Link](https://x.com/PsychedVantage/status/1901957475747631444) 2025-03-18T11:22Z [----] followers, [----] engagements "Form 8-K Filing Date March [--] [----] On March [--] [----] atai Life Sciences N.V. (the Company) announced that it has decided to add Bitcoin to its treasury reserve diversification strategy in addition to cash restricted cash cash equivalents short-term securities and public equity holdings. Over the next several weeks the Company expects to invest an initial position of $5.0 million in Bitcoin to hold as a treasury reserve asset. The Bitcoin treasury reserve is not anticipated to impact drug development timelines or current operational runway. $ATAI https://ir.atai.com/node/8931/html" [X Link](https://x.com/PsychedVantage/status/1902703584111677538) 2025-03-20T12:47Z [----] followers, [----] engagements "I will say hindsight is [----]. As a shareholder of $ATAI I am personally very pleased with how the company has positioned itself since this time. I love the terms of the investment with Beckley (excited about BPL-003/this investment really strengthened their catalyst table) and excited to see readouts of four phase [--] trials within the next [--] months 🤞 -Jake" [X Link](https://x.com/PsychedVantage/status/1906338635240091988) 2025-03-30T13:32Z [----] followers, [---] engagements "Very brief thoughts on RL-007 for CIAS (currently [--] approved treatments for CIAS) for $ATAI: -Topline data is expected mid [----]. -Analysts assign RL-007 a 25% POS (probability of success). -RL-007 has shown consistent pro-cognitive effects in preclinical Phase [--] and Phase [--] trials (at lower doses). One of the Phase 2s was a small trial in CIAS patients. Key questions I have heading into the readout: - RL-007 requires TID (three times daily) dosing which presents a major adherence challenge in neuropsychiatric conditions especially schizophrenia. - CEO Srini Rao previously suggested that" [X Link](https://x.com/PsychedVantage/status/1916153698931155382) 2025-04-26T15:33Z [----] followers, [---] engagements "PK/PD profile of VLS-01 and BPL-003 $ATAI" [X Link](https://x.com/PsychedVantage/status/1916184280285200412) 2025-04-26T17:35Z [----] followers, [---] engagements "Cybin to Participate at the 28th Annual Milken Institute Global Conference $CYBN https://ir.cybin.com/investors/news/news-details/2025/Cybin-to-Participate-at-the-28th-Annual-Milken-Institute-Global-Conference/default.aspx https://ir.cybin.com/investors/news/news-details/2025/Cybin-to-Participate-at-the-28th-Annual-Milken-Institute-Global-Conference/default.aspx" [X Link](https://x.com/PsychedVantage/status/1917917526295564694) 2025-05-01T12:22Z [----] followers, [---] engagements "Otsuka Signs Joint Research Agreement with Keio University Industry-academia collaboration for infrastructure development toward the social implementation of psychedelics in Japan https://www.otsuka.co.jp/en/company/newsreleases/2025/20250508_1.html https://www.otsuka.co.jp/en/company/newsreleases/2025/20250508_1.html" [X Link](https://x.com/PsychedVantage/status/1920561735896862763) 2025-05-08T19:29Z [----] followers, [---] engagements "Form: 8-K Description: Report of unscheduled material events or corporate event $ATAI https://ir.atai.com/static-files/3edc45f5-44e9-4f4d-87e6-2d286e6b87ac https://ir.atai.com/static-files/3edc45f5-44e9-4f4d-87e6-2d286e6b87ac" [X Link](https://x.com/PsychedVantage/status/1920615088534192319) 2025-05-08T23:01Z [----] followers, [---] engagements "Mid [----] could indeed be July. Could also be in late June. Will be interesting to see how $ATAI and $CYBN time their PRs around the $CMPS data. These dates all look pretty accurate to me. (Some could be off by a month or two. For example when a company states 1H [----] or 2H lots of room for interpretation). I think phase [--] initiation in September for $GHRS might be a bit hopeful. Could be wrong though. Only thing I would add to this is EMP-01 readout for $ATAI Q1 [----]. Also some readouts from private companies such as Gilgamesh. Overall nice catalyst map here. -Jake" [X Link](https://x.com/PsychedVantage/status/1920658841944870977) 2025-05-09T01:55Z [----] followers, [---] engagements "atai Life Sciences Announces First Patient Dosed in Phase [--] Study of EMP-01 for the Treatment of Social Anxiety Disorder $ATAI https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-announces-first-patient-dosed-phase-2-study https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-announces-first-patient-dosed-phase-2-study" [X Link](https://x.com/PsychedVantage/status/1922246231679492219) 2025-05-13T11:03Z [----] followers, [---] engagements "atai Life Sciences Reports First Quarter [----] Financial Results and Recent Corporate Updates $ATAI https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-reports-first-quarter-2025-financial-results https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-reports-first-quarter-2025-financial-results" [X Link](https://x.com/PsychedVantage/status/1922616844461990025) 2025-05-14T11:35Z [----] followers, [---] engagements "Last chance to send in questions -Jake $GHRS $MNMD $CMPS $ATAI $CYBN Hello everyone Jake here: Going to try something new here. On May 15th (after my finals) Id love to record a video answering questions from our followers on X. Drop any questions you have below and hit the like button on the ones you most want to see answered. Some Hello everyone Jake here: Going to try something new here. On May 15th (after my finals) Id love to record a video answering questions from our followers on X. Drop any questions you have below and hit the like button on the ones you most want to see answered. Some" [X Link](https://x.com/PsychedVantage/status/1922834278737440801) 2025-05-15T01:59Z [----] followers, [---] engagements "Cybin Engages Thermo Fisher Scientific to Provide U.S.-Based Manufacturing for its CYB003 Program for the Adjunctive Treatment of Major Depressive Disorder $CYBN https://ir.cybin.com/investors/news/news-details/2025/Cybin-Engages-Thermo-Fisher-Scientific-to-Provide-U-S--Based-Manufacturing-for-its-CYB003-Program-for-the-Adjunctive-Treatment-of-Major-Depressive-Disorder/default.aspx" [X Link](https://x.com/PsychedVantage/status/1922978188767949111) 2025-05-15T11:31Z [----] followers, [---] engagements "Find me a drug that was commercialized for depression where the anti-depressant effects of this drug were first discovered in pre-clinical studies. Go #biotech #MentalHealth $GHRS $MNMD $CMPS $ATAI $CYBN" [X Link](https://x.com/PsychedVantage/status/1923395237222780961) 2025-05-16T15:08Z [----] followers, [---] engagements "More details on @atai_lifes licensing agreement with @psilera for their DMT patent portfolio $ATAI Some other interesting findings in this 10-Q include $ATAI reducing their global workforce by 25% in March @BeckleyPsytech drawing down the final $10 million in escrow on April 1st. As mentioned in previous PR On May [--] [----] the Company repaid in full the outstanding indebtedness of $21.8 million and terminated all commitments and obligations under the Hercules Loan Agreement. The early prepayment saved atai approximately $2.1 million of interest otherwise due under the full amortization payment" [X Link](https://x.com/PsychedVantage/status/1923790630674702593) 2025-05-17T17:20Z [----] followers, [----] engagements "Q&A with Jake Setting Expectations for $CMPS Data https://www.youtube.com/watchv=ywY0G9TZlT8 https://www.youtube.com/watchv=ywY0G9TZlT8" [X Link](https://x.com/PsychedVantage/status/1924787148093362385) 2025-05-20T11:19Z [----] followers, [----] engagements "Its always nice to see psychedelic drug development company stocks doing well. But I remind myself: nothing matters if the data isnt positive. (If youre trading these stocks be aware of when clinical trials are expected to read out). $CMPS COMP005 top-line data expected late June (Limited disclosure expected in late June. No response or remission rates no baseline MADRS reduction reported from each arm. Warrants at $5.796 become exercisable after 26-week results and expire in [--] years). $ATAI BPL-003 data expected mid year (treatment-resistant depression) $CYBN CYB004 data anticipated mid year" [X Link](https://x.com/PsychedVantage/status/1924928747653755322) 2025-05-20T20:42Z [----] followers, [---] engagements "Highly recommend listening to this: [----] RBC Capital Markets Global Healthcare Conference $CMPS https://kvgo.com/rbc/compass-pathways-plc-may-2025 https://kvgo.com/rbc/compass-pathways-plc-may-2025" [X Link](https://x.com/PsychedVantage/status/1925134625518592212) 2025-05-21T10:20Z [----] followers, [---] engagements "2025 RBC Capital Markets Global Healthcare Conference $MNMD https://kvgo.com/rbc/mind-medicine-inc-may-2025 https://kvgo.com/rbc/mind-medicine-inc-may-2025" [X Link](https://x.com/PsychedVantage/status/1925253828229673015) 2025-05-21T18:14Z [----] followers, [---] engagements "GH001 IDR in PPD MADRS Total Scores for Individual Patients With PPD Treated With GH001 $GHRS GH Research poster presentations: $GHRS https://t.co/CFR0vCEznA GH Research poster presentations: $GHRS https://t.co/CFR0vCEznA" [X Link](https://x.com/PsychedVantage/status/1925443801948074192) 2025-05-22T06:49Z [----] followers, [----] engagements "@Zetaboy69 That is definitely fair to point out. Much more research needed undoubtedly. So far benefit risk profile of GH001 IDR looks good as of now (phase 2b data out to [--] months with multipe re-treatments). -Jake" [X Link](https://x.com/PsychedVantage/status/1925663424983244847) 2025-05-22T21:21Z [----] followers, [--] engagements "Could be the case. Benefit/risk ratio with individualized dosing regimen for GH-001 looks good so far. 73% remission in TRD population at [--] month follow up is noteworthy (average of [--] treatments in [--] month period). Otsuka acquired Mindset Pharma. I think Gilgamesh (strong IP) could be another potential acquisition target. Time will tell. -Jake" [X Link](https://x.com/PsychedVantage/status/1929249041445261564) 2025-06-01T18:49Z [----] followers, [--] engagements "@FrankRi53999857 @BiotechCH @insidepharma 🍄 🤝 🏳🌈 💪" [X Link](https://x.com/PsychedVantage/status/1929296173010956535) 2025-06-01T21:57Z [----] followers, [---] engagements "atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies $ATAI https://www.globenewswire.com/news-release/2025/06/02/3091657/0/en/atai-Life-Sciences-and-Beckley-Psytech-to-Combine-Creating-a-Global-Leader-in-Psychedelic-Mental-Health-Therapies.html https://www.globenewswire.com/news-release/2025/06/02/3091657/0/en/atai-Life-Sciences-and-Beckley-Psytech-to-Combine-Creating-a-Global-Leader-in-Psychedelic-Mental-Health-Therapies.html" [X Link](https://x.com/PsychedVantage/status/1929479475869147324) 2025-06-02T10:05Z [----] followers, [---] engagements "atai and Beckley Strategic Merger Webcast June [--] [----] 8:00 AM EDT $ATAI https://ir.atai.com/events/event-details/atai-and-beckley-strategic-merger https://ir.atai.com/events/event-details/atai-and-beckley-strategic-merger" [X Link](https://x.com/PsychedVantage/status/1929489523555099009) 2025-06-02T10:45Z [----] followers, [---] engagements "Very exciting news today from @atai_life and @BeckleyPsytech: the two psychedelic biotechs are planning to merge creating a powerhouse focused on researching and developing short-duration psychedelic compounds. Two months ago I (Jake) had the chance to speak with @C_Angermayer founder of atai Life Sciences after he announced an additional $22.75 million USD investment in $ATAI. Topics of that interview included: Why Christian chose to invest more in atai now. Why the S&P Biotech ETF (XBI) does not fully reflect the biotech bear market particularly with respect to small and mid-cap companies." [X Link](https://x.com/PsychedVantage/status/1929593164215558551) 2025-06-02T17:37Z [----] followers, [---] engagements "$ATAI - Will be hard to compare BPL-003 results with $GHRS considering they had earlier endpoint and aggressive re-treatment criteria in open label. (Average of [--] treatments with IDR in [--] month period). - Will be easier to compare with $CMPS phase 2b data though (similar trial design) and will be interested to see what type of dose response we might see in BPL003 trial. Curious if [--] mg might have similar efficacy (maybe less durability though) to [--] mg with less side effects. -Jake - Nailed response rate prediction here with 60% at day [--] ✅. - Close but no cigar on remission. - Way off on" [X Link](https://x.com/PsychedVantage/status/1930269171905970645) 2025-06-04T14:23Z [----] followers, [----] engagements "Hello everyone Jake here 👋 As mentioned previously Ill be outside of the country for most of June. This page MIGHT be a bit quiet during this time. If you want to stay on top of breaking news I recommend visiting the Investor Relations section on the website of any company youre following to set up email alerts directly from the source. For those interested in understanding the potential implications of upcoming trial data when it comes out including the $CMPS data expected in late June and potentially data from $ATAI as well I highly recommend following @Psyched_Alpha. Subscribing to PA+" [X Link](https://x.com/PsychedVantage/status/1931407785696125338) 2025-06-07T17:47Z [----] followers, [----] engagements "H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference $ATAI https://journey.ct.events/view/6bd0f8fe-b556-4ecc-a880-3b01d8dea542 https://journey.ct.events/view/6bd0f8fe-b556-4ecc-a880-3b01d8dea542" [X Link](https://x.com/PsychedVantage/status/1934946696569475507) 2025-06-17T12:10Z [----] followers, [---] engagements "Who Will Own the God Molecule Psychedelics devotees are racing biotech entrepreneurs to turn 5-MeO-DMT into a pharmaceutical. $GHRS $ATAI https://nymag.com/intelligencer/article/god-particle-5-meo-dmt-drug-pharmaceutical-market.html https://nymag.com/intelligencer/article/god-particle-5-meo-dmt-drug-pharmaceutical-market.html" [X Link](https://x.com/PsychedVantage/status/1935750168181407953) 2025-06-19T17:22Z [----] followers, [----] engagements "Results from the largest blinded RCTs of Psilocybin and a short duration psychedelic are expected to read out soon. 🍄 🐸 Results we have been waiting to see for years. How are we all feeling $CMPS $ATAI Extremely optimistic Cautiously optimistic Extremely pessimistic Cautiously pessimistic Extremely optimistic Cautiously optimistic Extremely pessimistic Cautiously pessimistic" [X Link](https://x.com/PsychedVantage/status/1936042196681023735) 2025-06-20T12:43Z [----] followers, [----] engagements "Hard to say much with the limited data disclosure. Big picture win for $CMPS and the entire space IMO. I was not a buyer before this readout because of limited data disclosure and single dose of psilocybin before primary endpoint and felt the market would ignore this context. This study very much was focused on saftey hence the inactive placebo in this study. (FDA requests this for 1/2 of the phase [--] studies). Seems that two doses three weeks apart might be important with this psychedelic. Results (based on what we can see now) met my expectations. Hoping $ATAI data is positive 🤞. -Jake" [X Link](https://x.com/PsychedVantage/status/1937122254359343456) 2025-06-23T12:15Z [----] followers, [---] engagements "COMPASS Pathways Investor Presentation June [----] $CMPS https://s204.q4cdn.com/927483861/files/doc_presentation/2025/COMPASS-Pathways-investor-presentation_June_2025-post-005_final-for-posting.pdf https://s204.q4cdn.com/927483861/files/doc_presentation/2025/COMPASS-Pathways-investor-presentation_June_2025-post-005_final-for-posting.pdf" [X Link](https://x.com/PsychedVantage/status/1937211927375073608) 2025-06-23T18:11Z [----] followers, [----] engagements "@DrAdamBorecky @Noname64290116 Really appreciate the responses 🙏. Looking forward to seeing more results from $ATAI and $CYBN this year. An exciting time for innovation in interventional psychiatry -Jake" [X Link](https://x.com/PsychedVantage/status/1937277637044375887) 2025-06-23T22:32Z [----] followers, [---] engagements "@alphaporgs Great question. From my understanding the FDA has no power to invalidate patents. But public comments from HHS leadership can potentially influence the narrative policymaking or payer sentiment. -Jake" [X Link](https://x.com/PsychedVantage/status/1939049976660705339) 2025-06-28T19:55Z [----] followers, [--] engagements "That is exactly what is written in the risk factors that "non-profits" may be willing to offer the drug for free. Usona has very deep pockets as well. It is thought that generic psilocybin might infringe on $CMPS IP and I am still trying to learn more about this. I think $CMPS will be trying to create a moat around COMP360 treatment outside of IP directly on the drug. -Jake" [X Link](https://x.com/PsychedVantage/status/1939068338509951243) 2025-06-28T21:08Z [----] followers, [---] engagements "As someone long in this space $ATAI $GHRS (and very recently $CMPS) I am always trying to look at potential short/medium/longterm bear case of tickers I own. All eyes are now on $ATAI BPL-003 readout. Investor expectations for these readouts matter (as we can see based on market reaction to $CMPS limited disclosure of data). Positive trial data doesnt always cut it. From my own research and through conversations with others here are potential bear cases for BPL-003 readout: - The risk is that even if BPL-003 data is positive it may unfairly be compared to $GHRS data which had [--] day endpoint" [X Link](https://x.com/PsychedVantage/status/1939283737839116755) 2025-06-29T11:24Z [----] followers, [----] engagements "Encouraging anecdote for EMP-01s potential in SAD alongside existing MDMA data for social anxiety in ASD. $ATAI Jake Lorde Gets Over Stage Fright with MDMA-Assisted Therapy Speaking with Stephen Colbert on The Late Show Kiwi singer Lorde said that MDMA-assisted therapy truly changed the game on my stage fright. https://t.co/0OS6juNfUg Lorde Gets Over Stage Fright with MDMA-Assisted Therapy Speaking with Stephen Colbert on The Late Show Kiwi singer Lorde said that MDMA-assisted therapy truly changed the game on my stage fright. https://t.co/0OS6juNfUg" [X Link](https://x.com/PsychedVantage/status/1939404701302194437) 2025-06-29T19:24Z [----] followers, [----] engagements "Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures $CYBN https://ir.cybin.com/investors/news/news-details/2025/Cybin-Announces-Financing-of-up-to-US500-Million-Aggregate-Principal-Amount-of-Convertible-Debentures/default.aspx https://ir.cybin.com/investors/news/news-details/2025/Cybin-Announces-Financing-of-up-to-US500-Million-Aggregate-Principal-Amount-of-Convertible-Debentures/default.aspx" [X Link](https://x.com/PsychedVantage/status/1939859820276068409) 2025-07-01T01:33Z [----] followers, [---] engagements "atai Life Sciences Announces $50 Million Private Placement Financing $ATAI https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-announces-50-million-private-placement https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-announces-50-million-private-placement" [X Link](https://x.com/PsychedVantage/status/1939990034918133789) 2025-07-01T10:10Z [----] followers, [---] engagements "@Waracken @atai_life @CybinInc @mindmedco @TrypTherapeutic @Pharmather_Inc 👀" [X Link](https://x.com/PsychedVantage/status/1940159392801825277) 2025-07-01T21:23Z [----] followers, [---] engagements "Corporate Presentation July [----] $CYBN https://s28.q4cdn.com/259445127/files/CYBN-Corporate-Deck-July-2025.pdf https://s28.q4cdn.com/259445127/files/CYBN-Corporate-Deck-July-2025.pdf" [X Link](https://x.com/PsychedVantage/status/1940162843900264744) 2025-07-01T21:37Z [----] followers, [---] engagements "@hildeshiem1 I am not. How about you -Jake" [X Link](https://x.com/PsychedVantage/status/1940782567575507038) 2025-07-03T14:39Z [----] followers, [--] engagements "$ARKG picking up shares of $CMPS and $ATAI makes you Bullish Bearish Neutral Bullish Bearish Neutral" [X Link](https://x.com/PsychedVantage/status/1941125584266162218) 2025-07-04T13:22Z [----] followers, [---] engagements "What a journey investing and trading in speculative biotech (during a bear market) has been over the past four years. The chart below does not reflect additional capital I added along the way. The biotech and psychedelic drug development portfolio is finally in the green though (+25% overall). All that just to underperform the S&P over the same period 🤪. That said Ive outperformed $XBI and $PSIL by a significant margin. Key tickers along the way: $AXSM $RLMD $BNOX $DRUG $MSSTF $MNMD $CYBN $ATAI $GHRS $CMPS Most valuable lessons so far: - To trade and invest in biotech it practically needs to" [X Link](https://x.com/PsychedVantage/status/1941246294091006238) 2025-07-04T21:22Z [----] followers, [--] engagements "Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th 8:00am ET $CMPS https://ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-to-Participate-in-HC-Wainwright-Home-Series-Interview-on-July-14th-800am-ET/default.aspx https://ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-to-Participate-in-HC-Wainwright-Home-Series-Interview-on-July-14th-800am-ET/default.aspx" [X Link](https://x.com/PsychedVantage/status/1943443488571355332) 2025-07-10T22:53Z [----] followers, [---] engagements "True or False: Psychedelic drug development company stocks are shifting from meme stocks to serious plays as mid/late-stage data show good safety & efficacy with intermittent dosing in hard-to-treat mental health conditions. $CMPS $MNMD $CYBN $ATAI $GHRS True False True False" [X Link](https://x.com/PsychedVantage/status/1943449356859748368) 2025-07-10T23:16Z [----] followers, [----] engagements "Favorite analyst covering psychedelic drug development stocks: Comment if you have another favorite $CMPS $MNMD $CYBN $ATAI $GHRS Ritu Baral Andrew Tsai Paul Matteis Elemer Piros PhD Ritu Baral Andrew Tsai Paul Matteis Elemer Piros PhD" [X Link](https://x.com/PsychedVantage/status/1943454804791169358) 2025-07-10T23:38Z [----] followers, [----] engagements "Am I going crazy or is there really not one late-stage development program looking at classic psychedelics to treat substance use disorders $CMPS $MNMD $CYBN $ATAI $GHRS -Jake" [X Link](https://x.com/PsychedVantage/status/1944467157280039326) 2025-07-13T18:41Z [----] followers, [----] engagements "$GHRS hits $1B market cap. All eyes now on the FDAs decision on the clinical hold" [X Link](https://x.com/PsychedVantage/status/1944801448291917862) 2025-07-14T16:49Z [----] followers, [---] engagements "@C_Angermayer What % of cash reserves would you consider prudent for $ATAI to hold in Bitcoin -Jake" [X Link](https://x.com/PsychedVantage/status/1945471626465681909) 2025-07-16T13:12Z [----] followers, [---] engagements "Cybin - Cybin Receives UK MHRA Approval to Commence EMBRACE A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder $CYBN https://ir.cybin.com/investors/news/news-details/2025/Cybin-Receives-UK-MHRA-Approval-to-Commence-EMBRACE-A-Multinational-Pivotal-Study-Evaluating-CYB003-for-the-Adjunctive-Treatment-of-Major-Depressive-Disorder/default.aspx" [X Link](https://x.com/PsychedVantage/status/1945808555879100580) 2025-07-17T11:31Z [----] followers, [---] engagements "Compass Pathways to Announce Second Quarter Financial Results on July [--] [----] $CMPS https://www.businesswire.com/news/home/20250722516595/en/Compass-Pathways-to-Announce-Second-Quarter-Financial-Results-on-July-31-2025 https://www.businesswire.com/news/home/20250722516595/en/Compass-Pathways-to-Announce-Second-Quarter-Financial-Results-on-July-31-2025" [X Link](https://x.com/PsychedVantage/status/1947614443564675113) 2025-07-22T11:07Z [----] followers, [----] engagements "@C_Angermayer 🍄 🐸 📊 💊 I like the risk/reward of $ANRO and $VTGN as well at these prices. Busy next 6-9 months with $ATAI readouts 🔥 🤞 -Jake" [X Link](https://x.com/PsychedVantage/status/1948027788465766785) 2025-07-23T14:29Z [----] followers, [---] engagements "@Brandon_Job23 @Psyched_Alpha No quite the opposite. -Jake" [X Link](https://x.com/PsychedVantage/status/1948034309719232556) 2025-07-23T14:55Z [----] followers, [--] engagements "@Brandon_Job23 @Psyched_Alpha Looking more likely that $ATAI will beat $GHRS to market in U.S. Very complex situation though. I recommend reading this: -Jake https://psychedelicalpha.com/news/p%CE%B1-psychedelic-patent-analysis-a-mebufotenin-melee-dec-23-jan-24 https://psychedelicalpha.com/news/p%CE%B1-psychedelic-patent-analysis-a-mebufotenin-melee-dec-23-jan-24" [X Link](https://x.com/PsychedVantage/status/1948035086042972425) 2025-07-23T14:58Z [----] followers, [---] engagements "Had a very cautious stance until I saw its valuation become out of touch with reality (IMO) and purchased a large amount of shares in $2.40 range. Much more to my investment thesis in $CMPS. Very high risk/high reward play. Unfortunately rn I am exhausted but will try to give you a more complete answer later. -Jake" [X Link](https://x.com/PsychedVantage/status/1948093560634454112) 2025-07-23T18:51Z [----] followers, [---] engagements "@NFTLunatic They are not. This is why I labled this my neuropsychiatry drug development portfolio instead of purely psychedelic drug development. $ANRO investor presentation: $VTGN investor presentation: -Jake https://www.vistagen.com/static-files/0c45ce9b-da51-4a35-8a3b-ec2d06549a52 https://s204.q4cdn.com/951687249/files/doc_presentations/2025/Jun/30/Alto-Corporate-Deck_July-2025_V1.pdf https://www.vistagen.com/static-files/0c45ce9b-da51-4a35-8a3b-ec2d06549a52 https://s204.q4cdn.com/951687249/files/doc_presentations/2025/Jun/30/Alto-Corporate-Deck_July-2025_V1.pdf" [X Link](https://x.com/PsychedVantage/status/1948191496726790192) 2025-07-24T01:20Z [----] followers, [---] engagements "MindMed to Report Second Quarter [----] Financial Results on July [--] [----] $MNMD https://ir.mindmed.co/news-events/press-releases/detail/188/mindmed-to-report-second-quarter-2025-financial-results-on-july-31-2025 https://ir.mindmed.co/news-events/press-releases/detail/188/mindmed-to-report-second-quarter-2025-financial-results-on-july-31-2025" [X Link](https://x.com/PsychedVantage/status/1948337719224021498) 2025-07-24T11:01Z [----] followers, [---] engagements "Dear psychedelic drug developers Do you want to improve the already solid data being generated in mid-late-stage programs Consider adding tracks from this album in music playlists used in your clinical trials. Best regards. Jake $CMPS $MNMD $CYBN $ATAI $GHRS" [X Link](https://x.com/PsychedVantage/status/1948558434292695161) 2025-07-25T01:38Z [----] followers, [--] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@PsychedVantage Psychedelic Vantage
Psychedelic Vantage posts on X about $atai, $cybn, $cmps, $ghrs the most. They currently have [-------] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.
Engagements: [---] #
- [--] Week [-----] -45%
- [--] Month [------] -80%
- [--] Months [-------] +180%
- [--] Year [-------] +491%
Mentions: [--] #
- [--] Week [--] -44%
- [--] Month [--] -20%
- [--] Months [---] +64%
- [--] Year [---] +213%
Followers: [-------] #
- [--] Week [-----] +0.34%
- [--] Month [-----] +1.10%
- [--] Months [-----] +27%
- [--] Year [-----] +75%
CreatorRank: [---------] #
Social Influence
Social category influence stocks finance exchanges currencies countries us election technology brands travel destinations cryptocurrencies social networks
Social topic influence $atai #4, $cybn, $cmps #7, $ghrs #3, $mnmd, atai life #5, data, announces, in the, investment
Top accounts mentioned or mentioned by @atailife @cybininc @cangermayer @psychedalpha @c2412345 @flobrand @larswilde @gilgameshrx @cangermayers @brandonjob23 @4andahalffarm @advisorshares @insidepharma @beckleypsytech @waracken @bigdogback @compasspathway @smallpharma @mindsetpharma @atailifes
Top assets mentioned Atai Life Sciences B.V. (ATAI) COMPASS Pathways plc (CMPS) GH Research PLC (GHRS) Alto Neuroscience, Inc. (ANRO) AbbVie Inc (ABBV) Axsome Therapeutics, Inc (AXSM) Bitcoin (BTC) Johnson & Johnson (JNJ)
Top Social Posts
Top posts by engagements in the last [--] hours
"Excited to announce the latest episode of our show with host Adam Tubero and guest Jim Gilligan exploring the groundbreaking TRP-8803 IV psilocin delivery system by Tryp Get ready for expert insights and a deep dive into Tryp. #TrypTherapeutics $TRYPF https://youtu.be/4eqUll2eOOI https://youtu.be/4eqUll2eOOI"
X Link 2023-02-13T19:51Z [----] followers, [---] engagements
"Leaked footage of an $ATAI investor waiting for phase 1/2a results from DemeRx that atai had originally anticipated coming out in early [----] (according to [----] earnings report)"
X Link 2023-05-18T19:01Z [----] followers, [---] engagements
"Alright @mathovermyth new [--] month highs for $GHRS and $MSSTF. Give us the TA🔥"
X Link 2023-06-08T23:32Z [----] followers, [---] engagements
"Following the release of this news on June 22nd $MSSTF is up 20% trading at a $30.58 million dollar market cap making a new [--] month high at .30 a share"
X Link 2023-06-27T20:20Z [----] followers, [---] engagements
"You would have thought it was a full trading day with the volume coming in on some of these names. $DMTTF leading the way alongside $CYBIN(how about that volume 👀). A fantastic day for $ATAI as well"
X Link 2023-07-03T18:28Z [----] followers, [---] engagements
"Recently Adam had the opportunity to receive a ketamine infusion at a clinic in New Jersey. In this video Adam gives a detailed description of his experience. We hope you enjoy"
X Link 2023-07-12T19:02Z [---] followers, [---] engagements
"while I do not hold $NUMI I am rooting for them and I admire the loyalty of the company's investor. So my question to the $NUMI bulls is: Bullish or bearish on Q3 results set to be released on Monday July 17th Bullish Bearish Bullish Bearish"
X Link 2023-07-15T00:32Z [----] followers, [---] engagements
"Portfolio as it stands today: 50% in $ATAI 40% in $GHRS and 10% in $MSSTF (not financial advice). Would love to hear the breakdown of everyone else's holdings if they are invested in the sector"
X Link 2023-07-18T21:34Z [----] followers, [---] engagements
"@V_arrell Jealous of your entry point in $ATAI. $4.11 DCA for me.(bought dip more aggressively over the last [--] years the more the stock dropped) How are you feeling about $NUMI after Q3 results Still trying to form an opinion on those results myself"
X Link 2023-07-18T22:16Z [----] followers, [---] engagements
"@AdvisorShares @mindmedco @COMPASSPathway @atai_life Don't forget $GHRS and $CYBN 😉. Still waiting for $MSSTF to be added to the ETF 🧐"
X Link 2023-07-19T08:50Z [----] followers, [---] engagements
"Despite releasing stellar phase 2a (small trial) results for SPLO26(Intravenous DMT). @SmallPharma $DMTTF is trading at an all time low today. Following this company very closely"
X Link 2023-07-19T16:17Z [----] followers, [---] engagements
"$MSET approaching its [--] week high while the rest of the sector lags behind. Gotta wonder what is cooking up for @MindsetPharma right now"
X Link 2023-08-09T13:53Z [----] followers, [---] engagements
"$MSET continues the uptrend. New [--] week high today. Psychedelics Performance [--] YR %: $MSET $CMPS $ATAI $PSYK https://t.co/B1o9uTADMx Psychedelics Performance [--] YR %: $MSET $CMPS $ATAI $PSYK https://t.co/B1o9uTADMx"
X Link 2023-08-24T14:33Z [----] followers, [---] engagements
"🧵Just had the chance to watch @CybinInc $CYBN's R&D day video. I was extremely impressed. My personal biggest takeaway: 57% of participants so far in the phase 1/2a trial of CYBOO3 rated the CYB003 experience as the most or top [--] most meaningful experiences of their lives"
X Link 2023-09-04T19:01Z [---] followers, [----] engagements
"In case you missed it here is our most recent interview with @insidepharma talking about @CybinInc's $CYBN acquisition of @SmallPharma $DMTTF. Point [--] recently bought over [--] million shares in $CYBN. This is big time news. CYB003 results coming soon. https://www.youtube.com/watchv=1OceEJRCECM&t=117s https://www.youtube.com/watchv=1OceEJRCECM&t=117s"
X Link 2023-09-16T21:11Z [----] followers, [----] engagements
"🧵Bull case for $CYBN from @Serotonin2arec(These are just opinions and not financial advice): CYB003 is already confirmed to be shorter acting than Comp360 and phase 1/2a interim data showed 57% of trial participants in the phase [--] portion rated the CYB003 experience as the"
X Link 2023-09-18T23:17Z [---] followers, [----] engagements
"From our friend @Kukeon2022: "Otsuka and Cybin called bottom" in the sector with Otsuka acquiring @MindsetPharma $MSET and @CybinInc $CYBN acquiring @SmallPharma $DMTTF. Agree or disagree Agree Disagree Agree Disagree"
X Link 2023-09-26T02:59Z [----] followers, [---] engagements
"🧵 When speaking with VCs and angel investors we notice that these specific companies focused on drug development are what get these investors the most excited. [--]. @Delix_tx [--]. @GilgameshRX [--]. @BeckleyPsytech [--]. @TerranBio [--]. @psilera [--]. @MindstateDesign [--]. @Psylo_Bio"
X Link 2023-11-21T15:28Z [---] followers, [----] engagements
"8. @PangeaBotanica [--]. Onsero [--]. @FreedomBioInc Worth mentioning: Many of these same investors are also very excited about @AltoNeuro (precision psychiatry) and @BlackrockNeuro_ (BCI)"
X Link 2023-11-21T15:28Z [---] followers, [---] engagements
"@MedicalGoldCa "Another issue is the actual launch of a product. MAPS MDMA therapy is finding stiff competition from J&Js (NYSE: JNJ) Spravato which has been a big hit and is already available to patients." Spravato is for TRD MDMA is for PTSD. Two different indications"
X Link 2023-11-21T20:35Z [---] followers, [---] engagements
"Results were absolutely incredible. Results half as good in terms of MADRS score reduction and remission rates in larger trials would still be mind blowing"
X Link 2023-12-01T13:50Z [---] followers, [---] engagements
""Transcend's MDMA analog treatment showed rapid and persistent reduction in a small cohort of patients with severe PTSD according to data presented late Tuesday afternoon. The drug Methylone is a chemical analog of MDMA"
X Link 2023-12-05T23:19Z [---] followers, [---] engagements
"the more widely-known psychedelic treatment that is soon to reach the FDAs desk to treat PTSD. Methylone is not a hallucinogen but is psychoactive similar to Johnson & Johnsons esketamine drug Spravato.""
X Link 2023-12-05T23:19Z [---] followers, [--] engagements
"2 publicly traded companies we see potentially getting acquired or partnering with large pharma for certain programs: [--]. @brightmindsbio $DRUG [--]. @BetterLifeBio $BETRF"
X Link 2023-12-10T17:40Z [----] followers, [---] engagements
"is anticipated to be released before year end. According to leadership at Compass speaking at the 6th Annual Evercore ISI HealthCONx Conference: Top-line safety data from the trial is expected to be shared by year end with efficacy data coming in 2024"
X Link 2023-12-16T05:23Z [---] followers, [---] engagements
"Both companies have seen the share price of their stocks run up into these results. (Potentially due to @maps_pbc filing their NDA for MDMA-assisted therapy). With all this being said We at Psychedelic Insights wish everyone happy holidays. We are grateful for all of you"
X Link 2023-12-16T05:23Z [---] followers, [---] engagements
"Citadel Advisors LLC has increased their stake in $CMPS. More institutional money coming into the space. On November 14th they reported owning [-------] shares of the company. They own [-------] shares as of December 20th"
X Link 2024-01-02T21:40Z [---] followers, [---] engagements
"@mycopreneur I understand this viewpoint for sure and could discuss this point specifically more. Investing/money aside though I think its pretty reasonable to discuss importance of therapy component of PAT when dealing with people struggling with mental health immensely"
X Link 2024-01-03T00:08Z [---] followers, [--] engagements
"🧵 Announcement: I made a mistake in my reporting of Citadel and Paradigm increasing their stake in $CMPS: From SEC filing in the case with Citadel for example: [--] The percentages reported in this Schedule 13G are based upon [--------] Shares outstanding comprised of (i)"
X Link 2024-01-03T06:11Z [--] followers, [----] engagements
"🧵 The mental health crisis will be even more of a problem in the coming years unfortunately. When you go out to a nice restaurant and see a [--] year old on their iPad at a family dinner completely disconnected from reality kids having access to online pornography young people spending less and less time socializing the list goes on and on and on. this is literally a black mirror episode this is literally a black mirror episode"
X Link 2024-01-03T18:48Z [--] followers, [---] engagements
"Yeah how dare MAPS try to put emphasis on treating people who have risked their lives to protect our country with a therapy that has been shown in two phase [--] trials to keep 70% of people with treatment resistant PTSD in remission one year after therapy. (Sarcasm). Unsurprising that maps reveals their PBC to be a military specific counseling center The website is giving ROTC recruitment 🤮 Unsurprising that maps reveals their PBC to be a military specific counseling center The website is giving ROTC recruitment 🤮"
X Link 2024-01-05T15:25Z [--] followers, [----] engagements
"But MDMA-assisted psychotherapy with licensed mental health professionals is not available for those with PTSD. I support both the recreational and medical model but there is and needs to be a distinction. IMO -Jake @PaulAustin3w Do these people not know that MDMA is readily available in hundreds of cities around the planet right now @PaulAustin3w Do these people not know that MDMA is readily available in hundreds of cities around the planet right now"
X Link 2024-01-05T23:29Z [---] followers, [--] engagements
"But MDMA-assisted psychotherapy with licensed mental health professionals is not available for those with PTSD. And I hope this changes. -Jake @PaulAustin3w Do these people not know that MDMA is readily available in hundreds of cities around the planet right now @PaulAustin3w Do these people not know that MDMA is readily available in hundreds of cities around the planet right now"
X Link 2024-01-05T23:37Z [--] followers, [---] engagements
"@douchante @atai_life To start are you a licensed mental health professional -Jake"
X Link 2024-01-06T15:18Z [--] followers, [--] engagements
"@douchante @atai_life If not my personal opinion would be to go into Psychology/Social Work or another field related to mental health. I myself am in school for social work and hope one day I can receive this training. -Jake"
X Link 2024-01-06T15:22Z [---] followers, [--] engagements
"@KingFranklinIV @BrianBarnettMD @AbstractIdea12 How would offering psychedelic therapy to those with TRD/PTSD for example with licensed mental health professionals work out without the medical system -Jake"
X Link 2024-01-06T18:40Z [--] followers, [--] engagements
"Also as a psychiatrist surely you believe in the importance of being educated on mental health disorders. Not saying you HAVE to be licensed to be good at helping those navigate these experiences. However when it comes to working with vulnerable patient populations specifically surely there is a lot of value in being a licensed mental health professional. -Jake"
X Link 2024-01-06T18:43Z [---] followers, [--] engagements
"@junglejava1 Happy birthday"
X Link 2024-01-08T01:49Z [--] followers, [--] engagements
"@ysl_mask @cburniske I have no knowledge on crypto. Any value with Bitcoin besides from being what the next person is willing to pay for it -Jake"
X Link 2024-01-08T17:36Z [---] followers, [--] engagements
"The nature of drug development companies sometimes unfortunately. Not everyone can stomach the swings in biotech. Much of stock declining was macro/one of worst biotech bear markets ever and out of their control. Personally I could not be happier with how they have decided to use their cash and snipe opportunities with a company I view as being ridiculously undervalued. [--] million to buy 35.5% of Beckley was a steal in my opinion and an absolutely brilliant investment. In short term they now have three phase [--] readouts in [----] and one in phase [--]. And this is through their strategic"
X Link 2024-01-08T22:50Z [---] followers, [--] engagements
"@PierceARK I know you are excited about the potential of Psilocybin as am I. Keep an eye on these phase [--] readouts looking at 5-MeO-DMT coming this year. -Jake"
X Link 2024-01-09T15:08Z [--] followers, [--] engagements
"It is no secret that [----] has the potential to be a truly transformative year for the psychedelic medicine space. In preparation we have decided to step things up. We are now Psychedelic Vantage @PsychedVantage. We cannot wait to continue putting out more content this year. We will also be sharing our new website soon filled with articles on the psychedelic medicine investment space and more. Stay tuned"
X Link 2024-01-16T22:08Z [--] followers, [----] engagements
"Very big year for the company and the entire sector. I am keeping my eye on FDAs response to Lykos Therapeutics request to give priority review to MDMA-assisted Therapy. This would mean approval decision would take [--] months instead of [--] months. Then you have many company specific potential catalysts for $ATAI this year. Assuming the readouts from Beckley and Compass are good combined with an improving macro outlook for the market could be a big time year indeed. -Jake"
X Link 2024-01-22T23:03Z [---] followers, [--] engagements
"*5-MeO-DMT is the most powerful. DMT is the most powerful psychedelic in the world. It's naturally produced by the human body. It is fully metabolized in 15-30 minutes. It's in hundreds of plants & fungi spread around the world. No other psychedelic has these properties. Why is DMT everywhere DMT is the most powerful psychedelic in the world. It's naturally produced by the human body. It is fully metabolized in 15-30 minutes. It's in hundreds of plants & fungi spread around the world. No other psychedelic has these properties. Why is DMT everywhere"
X Link 2024-01-26T16:42Z [---] followers, [---] engagements
"Psychedelics combined with psychological support show best results in terms of anti-depressant effects when the person tripping"
X Link 2024-01-27T00:55Z [--] followers, [---] engagements
"Red Light Holland: Nourishing Minds From Meals to Mental Health @redlightholland $TRUFF $TRIP by @Waracken https://psychedelicvantage.com/2024/01/26/red-light-holland-nourishing-minds-from-meals-to-mental-health/ https://psychedelicvantage.com/2024/01/26/red-light-holland-nourishing-minds-from-meals-to-mental-health/"
X Link 2024-01-28T09:33Z [---] followers, [---] engagements
"Best YouTube channel about mental health and medication by a long shot. Stuck in the anxiety treatment dilemma 🔄😧 My latest video cuts through confusion comparing psychotherapy and medication and guiding you towards peace of mind 🧠 https://t.co/9ah6XevdF0 Stuck in the anxiety treatment dilemma 🔄😧 My latest video cuts through confusion comparing psychotherapy and medication and guiding you towards peace of mind 🧠 https://t.co/9ah6XevdF0"
X Link 2024-01-29T23:09Z [---] followers, [---] engagements
"@BioStockAnalyst @EliLillyandCo invested in the Series C. -Jake"
X Link 2024-02-02T14:01Z [---] followers, [---] engagements
"FDA approval for MDMA is going to happen this week. r/pennystocks Note: The FDA MAY accept the NDA and MAY give MDMA-assisted therapy priority review. In this case we would get an approval decision from the FDA most likely in [--] months time instead of [--] months"
X Link 2024-02-05T02:01Z [---] followers, [----] engagements
"Awakn Life Sciences Announces Listing on the Canadian Securities Exchange $AWKN $AWKNF https://www.newsfilecorp.com/release/197585/Awakn-Life-Sciences-Announces-Listing-on-the-Canadian-Securities-Exchange https://www.newsfilecorp.com/release/197585/Awakn-Life-Sciences-Announces-Listing-on-the-Canadian-Securities-Exchange"
X Link 2024-02-12T16:32Z [----] followers, [---] engagements
"Tryp Therapeutics to Tryptamine Therapeutics Australia Limited by: @Waracken $TRYP $TRYPF @TrypTherapeutic Brief breakdown discussing the information circular released for Tryp's Shareholder meeting https://psychedelicvantage.com/2024/02/15/tryp-therapeutics-to-tryptamine-therapeutics-australia-limited/ https://psychedelicvantage.com/2024/02/15/tryp-therapeutics-to-tryptamine-therapeutics-australia-limited/ https://psychedelicvantage.com/2024/02/15/tryp-therapeutics-to-tryptamine-therapeutics-australia-limited/"
X Link 2024-02-15T15:04Z [----] followers, [----] engagements
"I think a lot of work is being done on the non-hallucinogenic side of all of this for neurodegenerative diseases. Excited to eventually see data from Compass looking at autism spectrum disoder/ Mindmed looking at R-MDMA for social anxiety in autism spectrum disorder. So much exciting research going on"
X Link 2024-02-18T00:14Z [---] followers, [---] engagements
"News: @ClearmindCMND receives Patent Approval in China for treatment of binge behaviors $CMND Full Release:"
X Link 2024-02-26T16:07Z [---] followers, [---] engagements
"Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement $MNMD https://www.businesswire.com/news/home/20240307267521/en/Mind-Medicine-MindMed-Inc.-Announces-Pricing-of-Underwritten-Offering-of-Common-Shares-and-Concurrent-Private-Placement https://www.businesswire.com/news/home/20240307267521/en/Mind-Medicine-MindMed-Inc.-Announces-Pricing-of-Underwritten-Offering-of-Common-Shares-and-Concurrent-Private-Placement"
X Link 2024-03-07T12:21Z [---] followers, [---] engagements
"Mindmed $MNMD LSDs Future in Psychiatry https://youtu.be/L2pv_2eLZ6Esi=-uSdwg7Ng_fsx4O4 https://youtu.be/L2pv_2eLZ6Esi=-uSdwg7Ng_fsx4O4"
X Link 2024-03-12T00:18Z [---] followers, [----] engagements
"Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry $CYBN https://ir.cybin.com/investors/news/news-details/2024/Cybin-Announces-Publication-of-Research-Manuscript-in-the-Journal-of-Medicinal-Chemistry/default.aspx https://ir.cybin.com/investors/news/news-details/2024/Cybin-Announces-Publication-of-Research-Manuscript-in-the-Journal-of-Medicinal-Chemistry/default.aspx"
X Link 2024-04-18T11:32Z [---] followers, [---] engagements
"Tryp Therapeutics Provides Update on Plan of Arrangement With Exopharm Limited and Announces Voluntary Trading Halt $TRYPF https://www.accesswire.com/855838/tryp-therapeutics-provides-update-on-plan-of-arrangement-with-exopharm-limited-and-announces-voluntary-trading-halt https://www.accesswire.com/855838/tryp-therapeutics-provides-update-on-plan-of-arrangement-with-exopharm-limited-and-announces-voluntary-trading-halt"
X Link 2024-04-24T13:12Z [----] followers, [---] engagements
"MindMed to Present at Upcoming May Medical Conferences $MNMD https://www.businesswire.com/news/home/20240425701302/en/MindMed-to-Present-at-Upcoming-May-Medical-Conferences https://www.businesswire.com/news/home/20240425701302/en/MindMed-to-Present-at-Upcoming-May-Medical-Conferences"
X Link 2024-04-25T11:06Z [---] followers, [---] engagements
"Tryp Therapeutics and Exopharm Limited Announce Completion of Plan of Arrangement $TRYPF https://www.accesswire.com/858639/tryp-therapeutics-and-exopharm-limited-announce-completion-of-plan-of-arrangement https://www.accesswire.com/858639/tryp-therapeutics-and-exopharm-limited-announce-completion-of-plan-of-arrangement"
X Link 2024-05-01T20:33Z [----] followers, [---] engagements
"Reunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo Holdings https://finance.yahoo.com/news/reunion-neuroscience-inc-announces-103-103000336.html https://finance.yahoo.com/news/reunion-neuroscience-inc-announces-103-103000336.html"
X Link 2024-05-02T10:54Z [---] followers, [---] engagements
"MindMed to Host Conference Call and Webcast to Discuss First Quarter [----] Financial Results and Provide Business Update $MNMD https://www.businesswire.com/news/home/20240502898236/en/MindMed-to-Host-Conference-Call-and-Webcast-to-Discuss-First-Quarter-2024-Financial-Results-and-Provide-Business-Update https://www.businesswire.com/news/home/20240502898236/en/MindMed-to-Host-Conference-Call-and-Webcast-to-Discuss-First-Quarter-2024-Financial-Results-and-Provide-Business-Update"
X Link 2024-05-02T11:13Z [---] followers, [---] engagements
"If you follow the content that we put out on the Psychedelic Vantage YouTube channel then you will know that we have been very excited about the potential of short acting psychedelics for quite some time. We became even more optimistic about the potential of short acting psychedelics for a range of psychiatric indications when in [----] Small Pharma released phase 2a data showing that SPL026 (IV-administered NN-DMT) displayed rapid acting and durable anti-depressant effects in MDD. Many are now beginning to believe that the intensity of the psychedelic experience may be more important than the"
X Link 2024-05-08T01:22Z [----] followers, [---] engagements
"Abbreviations: MDD (major depressive disorder) GAD (generalized anxiety disorder) OCD (obsessive compulsive disorder) TRD (treatment resistant depression) AUD (alcohol use disorder)"
X Link 2024-05-08T03:18Z [---] followers, [---] engagements
"MindMed Reports First Quarter [----] Financial Results and Business Updates $MNMD https://ir.mindmed.co/news-events/press-releases/detail/145/mindmed-reports-first-quarter-2024-financial-results-and-business-updates https://ir.mindmed.co/news-events/press-releases/detail/145/mindmed-reports-first-quarter-2024-financial-results-and-business-updates"
X Link 2024-05-08T20:05Z [---] followers, [---] engagements
"AbbVie and @GilgameshRX Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders https://www.prnewswire.com/news-releases/abbvie-and-gilgamesh-pharmaceuticals-announce-collaboration-and-option-to-license-agreement-to-develop-next-generation-therapies-for-psychiatric-disorders-302143485.html https://www.prnewswire.com/news-releases/abbvie-and-gilgamesh-pharmaceuticals-announce-collaboration-and-option-to-license-agreement-to-develop-next-generation-therapies-for-psychiatric-disorders-302143485.html"
X Link 2024-05-13T13:19Z [---] followers, [---] engagements
"Skipping the Trip @abbvie x @GilgameshRX : The Epic of Gilgamesh Continued https://www.youtube.com/watchv=R98gJoO00-U https://www.youtube.com/watchv=R98gJoO00-U"
X Link 2024-05-21T16:41Z [---] followers, [---] engagements
"Cybin Appoints Dr. Atul Mahableshwarkar M.D. as Senior Vice President Clinical Development $CYBN https://ir.cybin.com/investors/news/news-details/2024/Cybin-Appoints-Dr.-Atul-Mahableshwarkar-M.D.-as-Senior-Vice-President-Clinical-Development/default.aspx https://ir.cybin.com/investors/news/news-details/2024/Cybin-Appoints-Dr.-Atul-Mahableshwarkar-M.D.-as-Senior-Vice-President-Clinical-Development/default.aspx"
X Link 2024-06-11T11:31Z [---] followers, [---] engagements
"MindMed Announces Constructive End-of-Phase [--] Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD) $MNMD https://www.businesswire.com/news/home/20240620626324/en/MindMed-Announces-Constructive-End-of-Phase-2-Meeting-with-U.S.-FDA-for-MM120-in-Generalized-Anxiety-Disorder-GAD https://www.businesswire.com/news/home/20240620626324/en/MindMed-Announces-Constructive-End-of-Phase-2-Meeting-with-U.S.-FDA-for-MM120-in-Generalized-Anxiety-Disorder-GAD"
X Link 2024-06-20T12:06Z [---] followers, [---] engagements
"MindMed to be Included in Russell [----] and Russell [----] Indexes $MNMD https://finance.yahoo.com/news/mindmed-included-russell-2000-russell-110000072.html https://finance.yahoo.com/news/mindmed-included-russell-2000-russell-110000072.html"
X Link 2024-06-28T11:38Z [---] followers, [---] engagements
"Amazing write up here by @PeterKolchinsky and Sarah Reed from RA Captial. RA Captial is currently invested in $GHRS $CYBN and $CMPS. They also invested in Delix Therapeutics Series A financing round in [----]. As of our knowledge they were one of the first blue chip life sciences investment firms to put money into psychedelic drug development. https://rapport.bio/all-stories/obvious-in-hindsight-financings-pricing-uncertainty-early-access https://rapport.bio/all-stories/obvious-in-hindsight-financings-pricing-uncertainty-early-access"
X Link 2024-07-15T04:47Z [---] followers, [----] engagements
"MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT) $MNMD https://finance.yahoo.com/news/mindmed-announces-issuance-patent-mm120-110000178.html https://finance.yahoo.com/news/mindmed-announces-issuance-patent-mm120-110000178.html"
X Link 2024-07-17T11:19Z [---] followers, [---] engagements
"IntelGenx Provides Update on Previously Announced Sale and Investment Solicitation Process As Phase [--] of the SISP did not result in alternative superior bids IntelGenx and atai Life Sciences AG (atai) have now initiated the process to complete the purchase and sale transaction. The parties currently expect to obtain final approval from the Qubec Superior Court (Commercial Division) and close the transaction prior to September [--] [----]. $ATAI"
X Link 2024-07-19T22:41Z [---] followers, [---] engagements
"MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer $MNMD https://www.businesswire.com/news/home/20240729857388/en/ https://www.businesswire.com/news/home/20240729857388/en/"
X Link 2024-07-29T12:04Z [---] followers, [---] engagements
"@Josh__Hardman Mindmed and Cybin raises were timely. -Jake"
X Link 2024-08-05T19:45Z [---] followers, [---] engagements
"MindMed to Host Conference Call and Webcast to Discuss Second Quarter [----] Financial Results and Provide Business Update $MNMD https://ir.mindmed.co/news-events/press-releases/detail/154/mindmed-to-host-conference-call-and-webcast-to-discuss-second-quarter-2024-financial-results-and-provide-business-update https://ir.mindmed.co/news-events/press-releases/detail/154/mindmed-to-host-conference-call-and-webcast-to-discuss-second-quarter-2024-financial-results-and-provide-business-update"
X Link 2024-08-06T12:43Z [---] followers, [---] engagements
"Mind Medicine (MindMed) Inc. Announces Proposed Public Offering $MNMD https://www.businesswire.com/news/home/20240808999979/en/Mind-Medicine-MindMed-Inc.-Announces-Proposed-Public-Offering https://www.businesswire.com/news/home/20240808999979/en/Mind-Medicine-MindMed-Inc.-Announces-Proposed-Public-Offering"
X Link 2024-08-09T10:47Z [---] followers, [---] engagements
"atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT) $ATAI https://finance.yahoo.com/news/atai-life-sciences-announces-positive-110000472.html https://finance.yahoo.com/news/atai-life-sciences-announces-positive-110000472.html"
X Link 2024-08-13T11:17Z [----] followers, [---] engagements
"MindMed Reports Second Quarter [----] Financial Results and Business Updates $MNMD https://finance.yahoo.com/news/mindmed-reports-second-quarter-2024-110000016.html https://finance.yahoo.com/news/mindmed-reports-second-quarter-2024-110000016.html"
X Link 2024-08-13T11:36Z [---] followers, [---] engagements
"@RCarhartHarris @drmikehart @TheBorisLab @dr_brein @joerogan @hubermanlab @TheoVon @Drug_Researcher There is also open label data from Compass n=20 Mindmed ran a study a while back and Cybin had great phase 2a data looking at their psilocybin analog as an adjunct treatment. More data needed of course. But looks good so far. -Jake"
X Link 2024-08-22T16:56Z [---] followers, [---] engagements
"White House announces rule that would cut insurance red tape over mental health and substance use disorder care https://www.google.com/urlq=https://www.cnn.com/2024/09/09/health/mental-health-parity-rule/index.html&source=gmail&ust=1725975788289000&usg=AOvVaw3tVapYr6HvsKUAocgadLRN&rct=i https://www.google.com/urlq=https://www.cnn.com/2024/09/09/health/mental-health-parity-rule/index.html&source=gmail&ust=1725975788289000&usg=AOvVaw3tVapYr6HvsKUAocgadLRN&rct=i"
X Link 2024-09-09T13:46Z [----] followers, [----] engagements
"@CulperResearch Did you guys cover your short position on $AXSM yet -Jake"
X Link 2024-09-19T14:30Z [----] followers, [----] engagements
"The purpose of this study is to determine the safety and feasibility of sequencing psilocybin therapy with a short-duration aiTBS protocol (Stanford Accelerated Intelligent Neuromodulation Therapy or SAINT) in individuals with treatment-resistant major depressive disorder. is great http://Clinicaltrials.gov https://clinicaltrials.gov/study/NCT06132178intr=COMP360&rank=7 https://clinicaltrials.gov/study/NCT06132178intr=COMP360&rank=7 http://Clinicaltrials.gov https://clinicaltrials.gov/study/NCT06132178intr=COMP360&rank=7 https://clinicaltrials.gov/study/NCT06132178intr=COMP360&rank=7"
X Link 2024-09-20T15:49Z [----] followers, [---] engagements
"Psychedelic Drug Development: What We Are Looking Out For $CMPS $MNMD $GHRS $ATAI $CYBN https://www.youtube.com/watchv=o7-4PML6K9M https://www.youtube.com/watchv=o7-4PML6K9M"
X Link 2024-09-27T17:34Z [----] followers, [---] engagements
"One prediction is already starting to come into play as $ATAI has begun selling their stake in $CMPS. Check out our new video where we touched on this: https://youtu.be/o7-4PML6K9Msi=pLHBd2Z5GhcshTCJ https://atai.gcs-web.com/node/8646/html What I will be watching out for in the next 4-8 months/predictions. I reserve the right to be wrong about predictions. None of this is financial advice. -Jake $CYBN will become first company in the space to receive FDA breakthrough therapy designation for two different programs. https://youtu.be/o7-4PML6K9Msi=pLHBd2Z5GhcshTCJ"
X Link 2024-09-28T00:22Z [----] followers, [----] engagements
"IntelGenx is Granted Court Approval of the Sale Proposal from atai Life Sciences AG $ATAI https://www.globenewswire.com/news-release/2024/10/02/2957030/0/en/IntelGenx-is-Granted-Court-Approval-of-the-Sale-Proposal-from-atai-Life-Sciences-AG.html https://www.globenewswire.com/news-release/2024/10/02/2957030/0/en/IntelGenx-is-Granted-Court-Approval-of-the-Sale-Proposal-from-atai-Life-Sciences-AG.html"
X Link 2024-10-02T16:25Z [----] followers, [---] engagements
"Up 450% today so far. This is why you set alerts when you hold individual stocks. No one at Psychedelic Vantage is currently holding $DRUG. None of this is financial advice. $DRUG also working with 5-HT2C agonists currently up 43% off this news. $DRUG also working with 5-HT2C agonists currently up 43% off this news"
X Link 2024-10-15T14:59Z [----] followers, [---] engagements
"Discovery of novel 5-HT2A receptor agonists with non-hallucinogenic potential and translational antidepressant drug-like profiles $ATAI https://ir.atai.life/static-files/d48833a8-bf0c-4abd-b886-58d87d0c83d4 https://ir.atai.life/static-files/d48833a8-bf0c-4abd-b886-58d87d0c83d4"
X Link 2024-10-16T17:35Z [----] followers, [---] engagements
"@NotGonnaNotGon Would you consider this engagement on high doses of classical psychedelics to be psychotherapy -Jake"
X Link 2024-10-22T12:48Z [----] followers, [---] engagements
"Compass Pathways to Announce Third Quarter Financial Results on October [--] [----] $CMPS https://www.businesswire.com/news/home/20241024060255/en/Compass-Pathways-to-Announce-Third-Quarter-Financial-Results-on-October-31-2024 https://www.businesswire.com/news/home/20241024060255/en/Compass-Pathways-to-Announce-Third-Quarter-Financial-Results-on-October-31-2024"
X Link 2024-10-24T11:02Z [----] followers, [---] engagements
"MindMed to Host Conference Call and Webcast to Discuss Third Quarter [----] Financial Results and Provide Business Update $MNMD https://www.businesswire.com/news/home/20241024456529/en/MindMed-to-Host-Conference-Call-and-Webcast-to-Discuss-Third-Quarter-2024-Financial-Results-and-Provide-Business-Update https://www.businesswire.com/news/home/20241024456529/en/MindMed-to-Host-Conference-Call-and-Webcast-to-Discuss-Third-Quarter-2024-Financial-Results-and-Provide-Business-Update"
X Link 2024-10-24T11:57Z [---] followers, [---] engagements
"Compass Pathways' Updates First and Second Movers MindMed and Cybin Approaching Phase [--] $CMPS $MNMD $CYBN https://www.youtube.com/watchv=NlMtncyEau4 https://www.youtube.com/watchv=NlMtncyEau4"
X Link 2024-11-03T21:05Z [---] followers, [----] engagements
"MindMed Reports Third Quarter [----] Financial Results and Business Updates $MNMD https://www.businesswire.com/news/home/20241107702200/en/MindMed-Reports-Third-Quarter-2024-Financial-Results-and-Business-Updates https://www.businesswire.com/news/home/20241107702200/en/MindMed-Reports-Third-Quarter-2024-Financial-Results-and-Business-Updates"
X Link 2024-11-07T21:05Z [---] followers, [---] engagements
"A lot of posts about RFK Jr. with people tagging $CMPS $ATAI $CYBN $MNMD $GHRS I dont know about you folks but RFK Jr. doesnt exactly seem pro-pharma to me. Either way not sure how much say this guy will have in our public health policies. -Jake"
X Link 2024-11-11T01:25Z [---] followers, [----] engagements
"atai Life Sciences Reports Third Quarter [----] Financial Results and Provides Corporate Updates $ATAI https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-reports-third-quarter-2024-financial-results https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-reports-third-quarter-2024-financial-results"
X Link 2024-11-13T13:03Z [---] followers, [---] engagements
"MindMed Appoints Gregg Pratt Ph.D. as Chief Regulatory and Quality Assurance Officer $MNMD https://www.businesswire.com/news/home/20241118653031/en/MindMed-Appoints-Gregg-Pratt-Ph.D.-as-Chief-Regulatory-and-Quality-Assurance-Officer https://www.businesswire.com/news/home/20241118653031/en/MindMed-Appoints-Gregg-Pratt-Ph.D.-as-Chief-Regulatory-and-Quality-Assurance-Officer"
X Link 2024-11-18T12:08Z [---] followers, [---] engagements
"A must follow account Procrastination and ADHD A match made in heaven ❤. or hell 🔥 Isn't it just being lazy 🛋 Or is there something deeper at play 🤔 🧠 Dive in and find out whats really going on 👇🏽 https://t.co/zDnOQhK6nS Procrastination and ADHD A match made in heaven ❤. or hell 🔥 Isn't it just being lazy 🛋 Or is there something deeper at play 🤔 🧠 Dive in and find out whats really going on 👇🏽 https://t.co/zDnOQhK6nS"
X Link 2024-11-21T21:05Z [---] followers, [---] engagements
"Like what I am reading about Makary so far and what I am hearing from him in podcasts: - Recognizes we eat and drink poison in America ✅ - Acknowledges vaccines DO NOT cause Autism ✅ (seems to agree with RFK Jr. on food and not his other dangerous and debunked takes ✅) - Believes psychedelics have the potential to to treat mental health conditions and wants rigorous clinical trials to prove this ✅ Have a great weekend everyone. -Jake Biotech should rip higher Monday Biotech should rip higher Monday"
X Link 2024-11-23T02:28Z [----] followers, [--] engagements
"Really liking what Im reading and hearing about Dr. Marty Makary so far: Recognizes that we eat and drink poison in America ✅ Acknowledges that vaccines DO NOT cause autism ✅ Seems to align with RFK Jr. on the need for better food quality but not on his other dangerous and debunked takes ✅ Believes psychedelics have the potential to treat mental health conditions and advocates for rigorous clinical trials to prove this ✅ Have a great weekend everyone. -Jake Biotech should rip higher Monday Biotech should rip higher Monday"
X Link 2024-11-23T02:32Z [----] followers, [----] engagements
"New clinical trial registration: Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder $ATAI https://clinicaltrials.gov/study/NCT06693609intr=EMP-01&rank=1 https://clinicaltrials.gov/study/NCT06693609intr=EMP-01&rank=1"
X Link 2024-11-24T16:15Z [---] followers, [---] engagements
"List of clinical trial readouts anticipated in the coming months. As we all know these timelines can be subject to change: $ATAI Q4 2024: - ELE-101 phase 2a top-line open label data in MDD. N=6-12 trial participants with depression - BPL-003 phase 2a top-line open label data in AUD. N=13 Q2 2025: - BPL-003 phase 2b top-line data in TRD. N=185. According to November company presentation slide [--] ( Patients entering the open-label extension are randomized to receive either a single 12mg dose or a biphasic 4mg and 8mg dose approximately [--] minutes apart. Total N changed due to an adjustment in"
X Link 2024-11-24T23:12Z [---] followers, [---] engagements
"MindMed Appoints Javier Muniz M.D. as Vice President of Research and Development Strategy $MNMD https://www.biospace.com/press-releases/mindmed-appoints-javier-muniz-m-d-as-vice-president-of-research-and-development-strategy https://www.biospace.com/press-releases/mindmed-appoints-javier-muniz-m-d-as-vice-president-of-research-and-development-strategy"
X Link 2024-12-03T13:31Z [---] followers, [---] engagements
"MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD) $MNMD https://www.businesswire.com/news/home/20241205425128/en/MindMed-Awarded-Innovation-Passport-Designation-by-the-United-Kingdom-UK-Innovative-Licensing-and-Access-Pathway-ILAP-Steering-Group-for-MM120-Orally-Disintegrating-Tablet-ODT-for-Generalized-Anxiety-Disorder-GAD"
X Link 2024-12-05T12:04Z [---] followers, [---] engagements
"Cybins Corporate Presentation December [----] $CYBN https://s28.q4cdn.com/259445127/files/CYBN-Corporate-Deck-December-2024-Website-Final.pdf https://s28.q4cdn.com/259445127/files/CYBN-Corporate-Deck-December-2024-Website-Final.pdf"
X Link 2024-12-10T20:55Z [---] followers, [---] engagements
"MindMed Announces First Patient Dosed in Phase [--] Voyage Study of MM120 in Generalized Anxiety Disorder (GAD) $MNMD https://www.businesswire.com/news/home/20241216046321/en/ https://www.businesswire.com/news/home/20241216046321/en/"
X Link 2024-12-16T12:53Z [---] followers, [---] engagements
"Beckley Psytech announces positive topline results from Phase IIa study of ELE-101 (IV psilocin benzoate) for Major Depressive Disorder https://www.beckleypsytech.com/posts/beckley-psytech-announces-positive-topline-results-from-phase-iia-study-of-ele-101-for-major-depressive-disorder https://www.beckleypsytech.com/posts/beckley-psytech-announces-positive-topline-results-from-phase-iia-study-of-ele-101-for-major-depressive-disorder"
X Link 2024-12-16T12:57Z [---] followers, [----] engagements
"Awakn Life Sciences Enters into Binding Letter of Intent for Acquisition of Awakn by Graft Polymer (UK) Plc $AWKNF https://www.newsfilecorp.com/release/233897/Awakn-Life-Sciences-Enters-into-Binding-Letter-of-Intent-for-Acquisition-of-Awakn-by-Graft-Polymer-UK-Plc https://www.newsfilecorp.com/release/233897/Awakn-Life-Sciences-Enters-into-Binding-Letter-of-Intent-for-Acquisition-of-Awakn-by-Graft-Polymer-UK-Plc"
X Link 2024-12-16T15:26Z [----] followers, [---] engagements
"MindMeds Corporate Presentation-December 2024: $MNMD https://d1io3yog0oux5.cloudfront.net/_25951dd8646049733b7a9ba6d9a4c850/mindmed/db/2265/21500/pdf/MindMed+Investor+Presentation+December+2024+.pdf https://d1io3yog0oux5.cloudfront.net/_25951dd8646049733b7a9ba6d9a4c850/mindmed/db/2265/21500/pdf/MindMed+Investor+Presentation+December+2024+.pdf"
X Link 2024-12-18T19:38Z [---] followers, [---] engagements
"MindMed to Be Added to the Nasdaq Biotechnology Index $MNMD https://www.businesswire.com/news/home/20241219955108/en/MindMed-to-Be-Added-to-the-Nasdaq-Biotechnology-Index https://www.businesswire.com/news/home/20241219955108/en/MindMed-to-Be-Added-to-the-Nasdaq-Biotechnology-Index"
X Link 2024-12-19T12:41Z [---] followers, [---] engagements
"@BiopharmIQ COMP360 data was pushed back to Q2 [----]. -Jake"
X Link 2024-12-23T03:54Z [---] followers, [---] engagements
"@psy_dao Looking forward to seeing the data Hopefully this data readout and the many others in the space across different compounds and indications in [----] will be positive. -Jake"
X Link 2024-12-30T23:41Z [----] followers, [--] engagements
"Hello Psychedelic Vantage community Jake here: After [--] months of believing that bi-phasic dosing was only recently introduced into the open label portion of Beckley Psytechs phase 2b trial it turns out that when $ATAIs original January [----] presentation came out showing Beckleys phase 2b trial design bi-phasic dosing was always part of the plan in the open label portion. I was able to find the January presentation online and as you will see bi-phasic dosing in open label portion of trial is mentioned in the footnotes on slide [--]. The only changes to the Beckley phase 2b trial since January is"
X Link 2024-12-31T03:56Z [---] followers, [---] engagements
"Happy new year everyone Who else is absolutely stoked for these big time clinical trial results in [----] (many were supposed to come in [----] but were pushed back) $GHRS phase 2b (Q1) $CYBN phase [--] (Q1) Reunion Neuroscience phase [--] readout in PPD Gilgamesh Pharmaceuticals with two phase 2s Beckley Psytech phase 2a in AUD phase 2b in TRD (Q2) $ATAI three phase [--] readouts Potential phase [--] readout from Transcend Therapeutics looking at Methylone in PTSD And of course $CMPS phase [--] (COMP005) (Q2) There may be other readouts but less clarity with guidance on some. For example $CMPS phase [--] in"
X Link 2025-01-01T21:42Z [---] followers, [---] engagements
"@BioTechTraderSD Or retail investors placing market orders instead of limit orders. I would know because when I first purchased this stock 2ish years ago and had not too much experience investing I sent the stock up 25% with a very small buy 😂. -Jake"
X Link 2025-01-02T18:04Z [---] followers, [---] engagements
"We cant forget the progress that has been made by $AXSM and $ITCI pretty recently. Great data from both companies. No space in depression research more important to watch than psychedelics/neuroplastogens especially for treatment resistant depression. Also excited about progress with SAINT TMS. -Jake I'm really bummed about $NMRA. I really want somebody to crack antidepresssants. I mean SSRIs are not great. It's so sad we can't do better. I'm really bummed about $NMRA. I really want somebody to crack antidepresssants. I mean SSRIs are not great. It's so sad we can't do better"
X Link 2025-01-02T20:11Z [---] followers, [----] engagements
"@BioTechTraderSD this is the first readout in the space in a long time where I feel that IF the data is positive (big what if of course) it wont sell off after at least not for a while. I could be wrong of course. Three reasons: [--]. Larger sample size than many readouts we have seen and it will be in TRD population. Historically it will be the 3rd largest after $MNMD and $CMPS. $MNMD data was spectacular but sold off later on (probably because MDMA was rejected) and $CMPS data didnt meet peoples expectations so the stock was shot down in late [----]. [--]. While phase 1/2a data for $GHRS was a"
X Link 2025-01-03T01:15Z [---] followers, [---] engagements
"I would like to defend MindMed here when it comes to psychotherapy outside of the clinical trial setting. My understanding is that in traditional anti-depressant drug trials participants can continue ongoing stable psychotherapy as long as it was established BEFORE the trial began and remains unchanged during the trial. -Jake I see your psychological support and I raise you - Mr. Mouse https://t.co/rtZQ9xvk5Z I see your psychological support and I raise you - Mr. Mouse https://t.co/rtZQ9xvk5Z"
X Link 2025-01-05T00:45Z [---] followers, [---] engagements
"atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health $ATAI https://www.globenewswire.com/news-release/2025/01/10/3007542/0/en/atai-Life-Sciences-Announces-Key-Leadership-Appointments-as-it-Advances-its-Pipeline-of-Novel-Psychedelic-Therapeutics-for-Mental-Health.html https://www.globenewswire.com/news-release/2025/01/10/3007542/0/en/atai-Life-Sciences-Announces-Key-Leadership-Appointments-as-it-Advances-its-Pipeline-of-Novel-Psychedelic-Therapeutics-for-Mental-Health.html"
X Link 2025-01-10T12:09Z [---] followers, [---] engagements
"Compass Pathways Announces Pricing of Underwritten Offering $CMPS https://ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-Announces-Pricing-of-Underwritten-Offering/default.aspx https://ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-Announces-Pricing-of-Underwritten-Offering/default.aspx"
X Link 2025-01-10T12:12Z [---] followers, [---] engagements
"According to what I have heard from $ATAI in other publicly available interviews: Since they are now operating less of a hub and spoke model and are focused a lot more on moving forward with their internal programs into later stages of development having Srini with his scientific background as CEO made sense. I really like the team at $ATAI. Honestly all big [--] publicly traded companies in this space have great teams. Night and day difference for many of them compared to when they first went public. -Jake"
X Link 2025-01-11T22:27Z [---] followers, [---] engagements
"@iamsigmaphi As an $ATAI shareholder I like it more than potentially getting diluted at these levels. I believe they still hold 10% of $CMPS despite $CMPS off their website. -Jake"
X Link 2025-01-11T22:34Z [---] followers, [---] engagements
"@iamsigmaphi I wonder when they start unloading more shares. Perhaps waiting for a run up in the $CMPS SP into phase [--] data. I would think they would spread out the sales. Will be interesting to follow. -Jake"
X Link 2025-01-11T23:15Z [---] followers, [---] engagements
"MindMeds Corporate Presentation January 2025: $MNMD https://d1io3yog0oux5.cloudfront.net/_80b2b065dd756bcc65a56ab23eb57ef8/mindmed/db/2265/21500/pdf/MindMed+January+2025+Corporate+Presentation.pdf https://d1io3yog0oux5.cloudfront.net/_80b2b065dd756bcc65a56ab23eb57ef8/mindmed/db/2265/21500/pdf/MindMed+January+2025+Corporate+Presentation.pdf"
X Link 2025-01-13T21:46Z [---] followers, [---] engagements
"7 months ago Kabir Nath (CEO of Compass Pathway) speaking about Big Pharmas lack of interest in late-stage first generation psychedelic drug development companies: $MNMD $GHRS $CMPS $ATAI $CYBN"
X Link 2025-01-13T22:02Z [---] followers, [----] engagements
"Let me state again: LEAST likely to be affected by overhyped RFK Jr. headlines (both to upside and downside) -Jake Stocks least likely to be affected by overhyped RFK Jr. headlines (both to upside and downside). I think there is only one correct answer here. Curious to see what this vote looks like. Comment if your answer is $MNMD: @elonmusk lets have the option for more choices in polls Stocks least likely to be affected by overhyped RFK Jr. headlines (both to upside and downside). I think there is only one correct answer here. Curious to see what this vote looks like. Comment if your answer"
X Link 2025-01-13T23:07Z [---] followers, [---] engagements
"@PsychedStocks @elonmusk When it comes to RFK Jr. headlines I 100% agree with you. Most upside with those names. Keep in mind poll was asking which stock would be LEAST affected. I am only mentioning this because I feel many misread the post based on the results of the poll so far lol. -Jake"
X Link 2025-01-14T02:03Z [---] followers, [---] engagements
"atai Life Sciences Company Presentation January 2025: $ATAI https://ir.atai.life/static-files/7d46c96f-e913-4dd8-bd34-6b39adef3a96 https://ir.atai.life/static-files/7d46c96f-e913-4dd8-bd34-6b39adef3a96"
X Link 2025-01-14T07:54Z [---] followers, [----] engagements
"Looked through all big [--] publicly traded psychedelic drug development company January presentations. Cybins most recent is from December. Only presentation I see noticeable changes in from previous presentations is from $ATAI. Seeing changes in atais company presentations from month to month has been a trend for $ATAI since they have been a public company for a variety of reasons. (Still big $ATAI bull I hold shares only company I have never moved out of since [----] (I averaged down quite a bit) but I feel the need to point this out)). What I notice: - Company states they have [--] clinical stage"
X Link 2025-01-14T08:45Z [---] followers, [----] engagements
"@imafordmustang You know I was really confident in $GHRS being the least likely to he affected positively or negatively by RFK Jr. headlines but when I think a bit more I can see $CMPS as the answer making sense. Curious to hear why $CMPS is your answer. -Jake"
X Link 2025-01-14T09:00Z [---] followers, [---] engagements
"@shroomgirl42 @imafordmustang You could be right about $CMPS I am not sure. They also just had a pretty brutal raise. I think $ATAI just needs the money. -Jake"
X Link 2025-01-14T14:37Z [---] followers, [---] engagements
"While not a change in $GHRS most recent presentation (previous one also showed this) it seems GH-003 (Intranasal 5-MeO-DMT) has been shelved. Forgot to mention this. Along with other changes to pipeline/plans of big [--] $CYBN CYB005 pre-clinical studies completion pushed back to [----]. Previous guidance (deep in SEC filings) stated completion in [----]. -Jake Looked through all big [--] publicly traded psychedelic drug development company January presentations. Cybins most recent is from December. Only presentation I see noticeable changes in from previous presentations is from $ATAI. Seeing changes"
X Link 2025-01-14T20:06Z [---] followers, [---] engagements
"Deep Track Capital LP reporting ownership of [-------] shares in $CMPS Deep Track Capital was also the lead investor for recent financing rounds by $MNMD and $CYBN in [----] $CMPS https://d18rn0p25nwr6d.cloudfront.net/CIK-0001816590/2425ebc1-2c1b-4244-b193-046948b9d970.pdf https://d18rn0p25nwr6d.cloudfront.net/CIK-0001816590/2425ebc1-2c1b-4244-b193-046948b9d970.pdf"
X Link 2025-01-17T21:15Z [---] followers, [---] engagements
"SPRAVATO (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression $JNJ https://www.jnj.com/media-center/press-releases/spravato-esketamine-approved-in-the-u-s-as-the-first-and-only-monotherapy-for-adults-with-treatment-resistant-depression https://www.jnj.com/media-center/press-releases/spravato-esketamine-approved-in-the-u-s-as-the-first-and-only-monotherapy-for-adults-with-treatment-resistant-depression"
X Link 2025-01-21T15:41Z [---] followers, [----] engagements
"Awakn Announces Positive Outcome of Pre-IND Meeting with FDA for AWKN-002 in Alcohol Use Disorder $AWKNF https://awaknlifesciences.com/awkn-002-pre-ind-fda https://awaknlifesciences.com/awkn-002-pre-ind-fda"
X Link 2025-01-21T17:33Z [----] followers, [---] engagements
"What are you most looking forward to seeing in the coming weeks and months Comment below why you chose your answer $MNMD $GHRS $CMPS $ATAI $CYBN RFK Jr. news Clinical trial data RFK Jr. news Clinical trial data"
X Link 2025-01-22T19:56Z [---] followers, [----] engagements
"Upcoming milestones $ATAI"
X Link 2025-01-26T20:33Z [---] followers, [---] engagements
"Is there a world where results of RFK Jr. senate vote is not a sell the news event Comment below with your thoughts. I am holding all of my shares in $ATAI and $GHRS through the RFK Jr. news either way (NOT financial advice just sharing what I am doing to be transparent along with avoiding accusations of causing FUD) -Jake $MNMD $CMPS $ATAI $CYBN Yes No Yes No"
X Link 2025-02-05T23:07Z [---] followers, [---] engagements
"atai Life Sciences Announces Proposed Public Offering of Common Shares $ATAI https://atai.gcs-web.com/news-releases/news-release-details/atai-life-sciences-announces-proposed-public-offering-common https://atai.gcs-web.com/news-releases/news-release-details/atai-life-sciences-announces-proposed-public-offering-common"
X Link 2025-02-12T21:04Z [----] followers, [----] engagements
"atai Life Sciences Announces First Patient Dosed in Elumina the Phase [--] Clinical Trial of VLS-01 for Treatment-Resistant Depression $ATAI https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-first-patient-dosed-elumina-phase-2 https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-first-patient-dosed-elumina-phase-2"
X Link 2025-03-11T11:09Z [----] followers, [----] engagements
"Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression $CMPS https://ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-Announces-Publication-of-Results-from-COMP004-Study-on-COMP360-Psilocybin-for-Treatment-Resistant-Depression/default.aspx https://ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-Announces-Publication-of-Results-from-COMP004-Study-on-COMP360-Psilocybin-for-Treatment-Resistant-Depression/default.aspx"
X Link 2025-03-18T11:22Z [----] followers, [----] engagements
"Form 8-K Filing Date March [--] [----] On March [--] [----] atai Life Sciences N.V. (the Company) announced that it has decided to add Bitcoin to its treasury reserve diversification strategy in addition to cash restricted cash cash equivalents short-term securities and public equity holdings. Over the next several weeks the Company expects to invest an initial position of $5.0 million in Bitcoin to hold as a treasury reserve asset. The Bitcoin treasury reserve is not anticipated to impact drug development timelines or current operational runway. $ATAI https://ir.atai.com/node/8931/html"
X Link 2025-03-20T12:47Z [----] followers, [----] engagements
"I will say hindsight is [----]. As a shareholder of $ATAI I am personally very pleased with how the company has positioned itself since this time. I love the terms of the investment with Beckley (excited about BPL-003/this investment really strengthened their catalyst table) and excited to see readouts of four phase [--] trials within the next [--] months 🤞 -Jake"
X Link 2025-03-30T13:32Z [----] followers, [---] engagements
"Very brief thoughts on RL-007 for CIAS (currently [--] approved treatments for CIAS) for $ATAI: -Topline data is expected mid [----]. -Analysts assign RL-007 a 25% POS (probability of success). -RL-007 has shown consistent pro-cognitive effects in preclinical Phase [--] and Phase [--] trials (at lower doses). One of the Phase 2s was a small trial in CIAS patients. Key questions I have heading into the readout: - RL-007 requires TID (three times daily) dosing which presents a major adherence challenge in neuropsychiatric conditions especially schizophrenia. - CEO Srini Rao previously suggested that"
X Link 2025-04-26T15:33Z [----] followers, [---] engagements
"PK/PD profile of VLS-01 and BPL-003 $ATAI"
X Link 2025-04-26T17:35Z [----] followers, [---] engagements
"Cybin to Participate at the 28th Annual Milken Institute Global Conference $CYBN https://ir.cybin.com/investors/news/news-details/2025/Cybin-to-Participate-at-the-28th-Annual-Milken-Institute-Global-Conference/default.aspx https://ir.cybin.com/investors/news/news-details/2025/Cybin-to-Participate-at-the-28th-Annual-Milken-Institute-Global-Conference/default.aspx"
X Link 2025-05-01T12:22Z [----] followers, [---] engagements
"Otsuka Signs Joint Research Agreement with Keio University Industry-academia collaboration for infrastructure development toward the social implementation of psychedelics in Japan https://www.otsuka.co.jp/en/company/newsreleases/2025/20250508_1.html https://www.otsuka.co.jp/en/company/newsreleases/2025/20250508_1.html"
X Link 2025-05-08T19:29Z [----] followers, [---] engagements
"Form: 8-K Description: Report of unscheduled material events or corporate event $ATAI https://ir.atai.com/static-files/3edc45f5-44e9-4f4d-87e6-2d286e6b87ac https://ir.atai.com/static-files/3edc45f5-44e9-4f4d-87e6-2d286e6b87ac"
X Link 2025-05-08T23:01Z [----] followers, [---] engagements
"Mid [----] could indeed be July. Could also be in late June. Will be interesting to see how $ATAI and $CYBN time their PRs around the $CMPS data. These dates all look pretty accurate to me. (Some could be off by a month or two. For example when a company states 1H [----] or 2H lots of room for interpretation). I think phase [--] initiation in September for $GHRS might be a bit hopeful. Could be wrong though. Only thing I would add to this is EMP-01 readout for $ATAI Q1 [----]. Also some readouts from private companies such as Gilgamesh. Overall nice catalyst map here. -Jake"
X Link 2025-05-09T01:55Z [----] followers, [---] engagements
"atai Life Sciences Announces First Patient Dosed in Phase [--] Study of EMP-01 for the Treatment of Social Anxiety Disorder $ATAI https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-announces-first-patient-dosed-phase-2-study https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-announces-first-patient-dosed-phase-2-study"
X Link 2025-05-13T11:03Z [----] followers, [---] engagements
"atai Life Sciences Reports First Quarter [----] Financial Results and Recent Corporate Updates $ATAI https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-reports-first-quarter-2025-financial-results https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-reports-first-quarter-2025-financial-results"
X Link 2025-05-14T11:35Z [----] followers, [---] engagements
"Last chance to send in questions -Jake $GHRS $MNMD $CMPS $ATAI $CYBN Hello everyone Jake here: Going to try something new here. On May 15th (after my finals) Id love to record a video answering questions from our followers on X. Drop any questions you have below and hit the like button on the ones you most want to see answered. Some Hello everyone Jake here: Going to try something new here. On May 15th (after my finals) Id love to record a video answering questions from our followers on X. Drop any questions you have below and hit the like button on the ones you most want to see answered. Some"
X Link 2025-05-15T01:59Z [----] followers, [---] engagements
"Cybin Engages Thermo Fisher Scientific to Provide U.S.-Based Manufacturing for its CYB003 Program for the Adjunctive Treatment of Major Depressive Disorder $CYBN https://ir.cybin.com/investors/news/news-details/2025/Cybin-Engages-Thermo-Fisher-Scientific-to-Provide-U-S--Based-Manufacturing-for-its-CYB003-Program-for-the-Adjunctive-Treatment-of-Major-Depressive-Disorder/default.aspx"
X Link 2025-05-15T11:31Z [----] followers, [---] engagements
"Find me a drug that was commercialized for depression where the anti-depressant effects of this drug were first discovered in pre-clinical studies. Go #biotech #MentalHealth $GHRS $MNMD $CMPS $ATAI $CYBN"
X Link 2025-05-16T15:08Z [----] followers, [---] engagements
"More details on @atai_lifes licensing agreement with @psilera for their DMT patent portfolio $ATAI Some other interesting findings in this 10-Q include $ATAI reducing their global workforce by 25% in March @BeckleyPsytech drawing down the final $10 million in escrow on April 1st. As mentioned in previous PR On May [--] [----] the Company repaid in full the outstanding indebtedness of $21.8 million and terminated all commitments and obligations under the Hercules Loan Agreement. The early prepayment saved atai approximately $2.1 million of interest otherwise due under the full amortization payment"
X Link 2025-05-17T17:20Z [----] followers, [----] engagements
"Q&A with Jake Setting Expectations for $CMPS Data https://www.youtube.com/watchv=ywY0G9TZlT8 https://www.youtube.com/watchv=ywY0G9TZlT8"
X Link 2025-05-20T11:19Z [----] followers, [----] engagements
"Its always nice to see psychedelic drug development company stocks doing well. But I remind myself: nothing matters if the data isnt positive. (If youre trading these stocks be aware of when clinical trials are expected to read out). $CMPS COMP005 top-line data expected late June (Limited disclosure expected in late June. No response or remission rates no baseline MADRS reduction reported from each arm. Warrants at $5.796 become exercisable after 26-week results and expire in [--] years). $ATAI BPL-003 data expected mid year (treatment-resistant depression) $CYBN CYB004 data anticipated mid year"
X Link 2025-05-20T20:42Z [----] followers, [---] engagements
"Highly recommend listening to this: [----] RBC Capital Markets Global Healthcare Conference $CMPS https://kvgo.com/rbc/compass-pathways-plc-may-2025 https://kvgo.com/rbc/compass-pathways-plc-may-2025"
X Link 2025-05-21T10:20Z [----] followers, [---] engagements
"2025 RBC Capital Markets Global Healthcare Conference $MNMD https://kvgo.com/rbc/mind-medicine-inc-may-2025 https://kvgo.com/rbc/mind-medicine-inc-may-2025"
X Link 2025-05-21T18:14Z [----] followers, [---] engagements
"GH001 IDR in PPD MADRS Total Scores for Individual Patients With PPD Treated With GH001 $GHRS GH Research poster presentations: $GHRS https://t.co/CFR0vCEznA GH Research poster presentations: $GHRS https://t.co/CFR0vCEznA"
X Link 2025-05-22T06:49Z [----] followers, [----] engagements
"@Zetaboy69 That is definitely fair to point out. Much more research needed undoubtedly. So far benefit risk profile of GH001 IDR looks good as of now (phase 2b data out to [--] months with multipe re-treatments). -Jake"
X Link 2025-05-22T21:21Z [----] followers, [--] engagements
"Could be the case. Benefit/risk ratio with individualized dosing regimen for GH-001 looks good so far. 73% remission in TRD population at [--] month follow up is noteworthy (average of [--] treatments in [--] month period). Otsuka acquired Mindset Pharma. I think Gilgamesh (strong IP) could be another potential acquisition target. Time will tell. -Jake"
X Link 2025-06-01T18:49Z [----] followers, [--] engagements
"@FrankRi53999857 @BiotechCH @insidepharma 🍄 🤝 🏳🌈 💪"
X Link 2025-06-01T21:57Z [----] followers, [---] engagements
"atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies $ATAI https://www.globenewswire.com/news-release/2025/06/02/3091657/0/en/atai-Life-Sciences-and-Beckley-Psytech-to-Combine-Creating-a-Global-Leader-in-Psychedelic-Mental-Health-Therapies.html https://www.globenewswire.com/news-release/2025/06/02/3091657/0/en/atai-Life-Sciences-and-Beckley-Psytech-to-Combine-Creating-a-Global-Leader-in-Psychedelic-Mental-Health-Therapies.html"
X Link 2025-06-02T10:05Z [----] followers, [---] engagements
"atai and Beckley Strategic Merger Webcast June [--] [----] 8:00 AM EDT $ATAI https://ir.atai.com/events/event-details/atai-and-beckley-strategic-merger https://ir.atai.com/events/event-details/atai-and-beckley-strategic-merger"
X Link 2025-06-02T10:45Z [----] followers, [---] engagements
"Very exciting news today from @atai_life and @BeckleyPsytech: the two psychedelic biotechs are planning to merge creating a powerhouse focused on researching and developing short-duration psychedelic compounds. Two months ago I (Jake) had the chance to speak with @C_Angermayer founder of atai Life Sciences after he announced an additional $22.75 million USD investment in $ATAI. Topics of that interview included: Why Christian chose to invest more in atai now. Why the S&P Biotech ETF (XBI) does not fully reflect the biotech bear market particularly with respect to small and mid-cap companies."
X Link 2025-06-02T17:37Z [----] followers, [---] engagements
"$ATAI - Will be hard to compare BPL-003 results with $GHRS considering they had earlier endpoint and aggressive re-treatment criteria in open label. (Average of [--] treatments with IDR in [--] month period). - Will be easier to compare with $CMPS phase 2b data though (similar trial design) and will be interested to see what type of dose response we might see in BPL003 trial. Curious if [--] mg might have similar efficacy (maybe less durability though) to [--] mg with less side effects. -Jake - Nailed response rate prediction here with 60% at day [--] ✅. - Close but no cigar on remission. - Way off on"
X Link 2025-06-04T14:23Z [----] followers, [----] engagements
"Hello everyone Jake here 👋 As mentioned previously Ill be outside of the country for most of June. This page MIGHT be a bit quiet during this time. If you want to stay on top of breaking news I recommend visiting the Investor Relations section on the website of any company youre following to set up email alerts directly from the source. For those interested in understanding the potential implications of upcoming trial data when it comes out including the $CMPS data expected in late June and potentially data from $ATAI as well I highly recommend following @Psyched_Alpha. Subscribing to PA+"
X Link 2025-06-07T17:47Z [----] followers, [----] engagements
"H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference $ATAI https://journey.ct.events/view/6bd0f8fe-b556-4ecc-a880-3b01d8dea542 https://journey.ct.events/view/6bd0f8fe-b556-4ecc-a880-3b01d8dea542"
X Link 2025-06-17T12:10Z [----] followers, [---] engagements
"Who Will Own the God Molecule Psychedelics devotees are racing biotech entrepreneurs to turn 5-MeO-DMT into a pharmaceutical. $GHRS $ATAI https://nymag.com/intelligencer/article/god-particle-5-meo-dmt-drug-pharmaceutical-market.html https://nymag.com/intelligencer/article/god-particle-5-meo-dmt-drug-pharmaceutical-market.html"
X Link 2025-06-19T17:22Z [----] followers, [----] engagements
"Results from the largest blinded RCTs of Psilocybin and a short duration psychedelic are expected to read out soon. 🍄 🐸 Results we have been waiting to see for years. How are we all feeling $CMPS $ATAI Extremely optimistic Cautiously optimistic Extremely pessimistic Cautiously pessimistic Extremely optimistic Cautiously optimistic Extremely pessimistic Cautiously pessimistic"
X Link 2025-06-20T12:43Z [----] followers, [----] engagements
"Hard to say much with the limited data disclosure. Big picture win for $CMPS and the entire space IMO. I was not a buyer before this readout because of limited data disclosure and single dose of psilocybin before primary endpoint and felt the market would ignore this context. This study very much was focused on saftey hence the inactive placebo in this study. (FDA requests this for 1/2 of the phase [--] studies). Seems that two doses three weeks apart might be important with this psychedelic. Results (based on what we can see now) met my expectations. Hoping $ATAI data is positive 🤞. -Jake"
X Link 2025-06-23T12:15Z [----] followers, [---] engagements
"COMPASS Pathways Investor Presentation June [----] $CMPS https://s204.q4cdn.com/927483861/files/doc_presentation/2025/COMPASS-Pathways-investor-presentation_June_2025-post-005_final-for-posting.pdf https://s204.q4cdn.com/927483861/files/doc_presentation/2025/COMPASS-Pathways-investor-presentation_June_2025-post-005_final-for-posting.pdf"
X Link 2025-06-23T18:11Z [----] followers, [----] engagements
"@DrAdamBorecky @Noname64290116 Really appreciate the responses 🙏. Looking forward to seeing more results from $ATAI and $CYBN this year. An exciting time for innovation in interventional psychiatry -Jake"
X Link 2025-06-23T22:32Z [----] followers, [---] engagements
"@alphaporgs Great question. From my understanding the FDA has no power to invalidate patents. But public comments from HHS leadership can potentially influence the narrative policymaking or payer sentiment. -Jake"
X Link 2025-06-28T19:55Z [----] followers, [--] engagements
"That is exactly what is written in the risk factors that "non-profits" may be willing to offer the drug for free. Usona has very deep pockets as well. It is thought that generic psilocybin might infringe on $CMPS IP and I am still trying to learn more about this. I think $CMPS will be trying to create a moat around COMP360 treatment outside of IP directly on the drug. -Jake"
X Link 2025-06-28T21:08Z [----] followers, [---] engagements
"As someone long in this space $ATAI $GHRS (and very recently $CMPS) I am always trying to look at potential short/medium/longterm bear case of tickers I own. All eyes are now on $ATAI BPL-003 readout. Investor expectations for these readouts matter (as we can see based on market reaction to $CMPS limited disclosure of data). Positive trial data doesnt always cut it. From my own research and through conversations with others here are potential bear cases for BPL-003 readout: - The risk is that even if BPL-003 data is positive it may unfairly be compared to $GHRS data which had [--] day endpoint"
X Link 2025-06-29T11:24Z [----] followers, [----] engagements
"Encouraging anecdote for EMP-01s potential in SAD alongside existing MDMA data for social anxiety in ASD. $ATAI Jake Lorde Gets Over Stage Fright with MDMA-Assisted Therapy Speaking with Stephen Colbert on The Late Show Kiwi singer Lorde said that MDMA-assisted therapy truly changed the game on my stage fright. https://t.co/0OS6juNfUg Lorde Gets Over Stage Fright with MDMA-Assisted Therapy Speaking with Stephen Colbert on The Late Show Kiwi singer Lorde said that MDMA-assisted therapy truly changed the game on my stage fright. https://t.co/0OS6juNfUg"
X Link 2025-06-29T19:24Z [----] followers, [----] engagements
"Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures $CYBN https://ir.cybin.com/investors/news/news-details/2025/Cybin-Announces-Financing-of-up-to-US500-Million-Aggregate-Principal-Amount-of-Convertible-Debentures/default.aspx https://ir.cybin.com/investors/news/news-details/2025/Cybin-Announces-Financing-of-up-to-US500-Million-Aggregate-Principal-Amount-of-Convertible-Debentures/default.aspx"
X Link 2025-07-01T01:33Z [----] followers, [---] engagements
"atai Life Sciences Announces $50 Million Private Placement Financing $ATAI https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-announces-50-million-private-placement https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-announces-50-million-private-placement"
X Link 2025-07-01T10:10Z [----] followers, [---] engagements
"@Waracken @atai_life @CybinInc @mindmedco @TrypTherapeutic @Pharmather_Inc 👀"
X Link 2025-07-01T21:23Z [----] followers, [---] engagements
"Corporate Presentation July [----] $CYBN https://s28.q4cdn.com/259445127/files/CYBN-Corporate-Deck-July-2025.pdf https://s28.q4cdn.com/259445127/files/CYBN-Corporate-Deck-July-2025.pdf"
X Link 2025-07-01T21:37Z [----] followers, [---] engagements
"@hildeshiem1 I am not. How about you -Jake"
X Link 2025-07-03T14:39Z [----] followers, [--] engagements
"$ARKG picking up shares of $CMPS and $ATAI makes you Bullish Bearish Neutral Bullish Bearish Neutral"
X Link 2025-07-04T13:22Z [----] followers, [---] engagements
"What a journey investing and trading in speculative biotech (during a bear market) has been over the past four years. The chart below does not reflect additional capital I added along the way. The biotech and psychedelic drug development portfolio is finally in the green though (+25% overall). All that just to underperform the S&P over the same period 🤪. That said Ive outperformed $XBI and $PSIL by a significant margin. Key tickers along the way: $AXSM $RLMD $BNOX $DRUG $MSSTF $MNMD $CYBN $ATAI $GHRS $CMPS Most valuable lessons so far: - To trade and invest in biotech it practically needs to"
X Link 2025-07-04T21:22Z [----] followers, [--] engagements
"Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th 8:00am ET $CMPS https://ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-to-Participate-in-HC-Wainwright-Home-Series-Interview-on-July-14th-800am-ET/default.aspx https://ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-to-Participate-in-HC-Wainwright-Home-Series-Interview-on-July-14th-800am-ET/default.aspx"
X Link 2025-07-10T22:53Z [----] followers, [---] engagements
"True or False: Psychedelic drug development company stocks are shifting from meme stocks to serious plays as mid/late-stage data show good safety & efficacy with intermittent dosing in hard-to-treat mental health conditions. $CMPS $MNMD $CYBN $ATAI $GHRS True False True False"
X Link 2025-07-10T23:16Z [----] followers, [----] engagements
"Favorite analyst covering psychedelic drug development stocks: Comment if you have another favorite $CMPS $MNMD $CYBN $ATAI $GHRS Ritu Baral Andrew Tsai Paul Matteis Elemer Piros PhD Ritu Baral Andrew Tsai Paul Matteis Elemer Piros PhD"
X Link 2025-07-10T23:38Z [----] followers, [----] engagements
"Am I going crazy or is there really not one late-stage development program looking at classic psychedelics to treat substance use disorders $CMPS $MNMD $CYBN $ATAI $GHRS -Jake"
X Link 2025-07-13T18:41Z [----] followers, [----] engagements
"$GHRS hits $1B market cap. All eyes now on the FDAs decision on the clinical hold"
X Link 2025-07-14T16:49Z [----] followers, [---] engagements
"@C_Angermayer What % of cash reserves would you consider prudent for $ATAI to hold in Bitcoin -Jake"
X Link 2025-07-16T13:12Z [----] followers, [---] engagements
"Cybin - Cybin Receives UK MHRA Approval to Commence EMBRACE A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder $CYBN https://ir.cybin.com/investors/news/news-details/2025/Cybin-Receives-UK-MHRA-Approval-to-Commence-EMBRACE-A-Multinational-Pivotal-Study-Evaluating-CYB003-for-the-Adjunctive-Treatment-of-Major-Depressive-Disorder/default.aspx"
X Link 2025-07-17T11:31Z [----] followers, [---] engagements
"Compass Pathways to Announce Second Quarter Financial Results on July [--] [----] $CMPS https://www.businesswire.com/news/home/20250722516595/en/Compass-Pathways-to-Announce-Second-Quarter-Financial-Results-on-July-31-2025 https://www.businesswire.com/news/home/20250722516595/en/Compass-Pathways-to-Announce-Second-Quarter-Financial-Results-on-July-31-2025"
X Link 2025-07-22T11:07Z [----] followers, [----] engagements
"@C_Angermayer 🍄 🐸 📊 💊 I like the risk/reward of $ANRO and $VTGN as well at these prices. Busy next 6-9 months with $ATAI readouts 🔥 🤞 -Jake"
X Link 2025-07-23T14:29Z [----] followers, [---] engagements
"@Brandon_Job23 @Psyched_Alpha No quite the opposite. -Jake"
X Link 2025-07-23T14:55Z [----] followers, [--] engagements
"@Brandon_Job23 @Psyched_Alpha Looking more likely that $ATAI will beat $GHRS to market in U.S. Very complex situation though. I recommend reading this: -Jake https://psychedelicalpha.com/news/p%CE%B1-psychedelic-patent-analysis-a-mebufotenin-melee-dec-23-jan-24 https://psychedelicalpha.com/news/p%CE%B1-psychedelic-patent-analysis-a-mebufotenin-melee-dec-23-jan-24"
X Link 2025-07-23T14:58Z [----] followers, [---] engagements
"Had a very cautious stance until I saw its valuation become out of touch with reality (IMO) and purchased a large amount of shares in $2.40 range. Much more to my investment thesis in $CMPS. Very high risk/high reward play. Unfortunately rn I am exhausted but will try to give you a more complete answer later. -Jake"
X Link 2025-07-23T18:51Z [----] followers, [---] engagements
"@NFTLunatic They are not. This is why I labled this my neuropsychiatry drug development portfolio instead of purely psychedelic drug development. $ANRO investor presentation: $VTGN investor presentation: -Jake https://www.vistagen.com/static-files/0c45ce9b-da51-4a35-8a3b-ec2d06549a52 https://s204.q4cdn.com/951687249/files/doc_presentations/2025/Jun/30/Alto-Corporate-Deck_July-2025_V1.pdf https://www.vistagen.com/static-files/0c45ce9b-da51-4a35-8a3b-ec2d06549a52 https://s204.q4cdn.com/951687249/files/doc_presentations/2025/Jun/30/Alto-Corporate-Deck_July-2025_V1.pdf"
X Link 2025-07-24T01:20Z [----] followers, [---] engagements
"MindMed to Report Second Quarter [----] Financial Results on July [--] [----] $MNMD https://ir.mindmed.co/news-events/press-releases/detail/188/mindmed-to-report-second-quarter-2025-financial-results-on-july-31-2025 https://ir.mindmed.co/news-events/press-releases/detail/188/mindmed-to-report-second-quarter-2025-financial-results-on-july-31-2025"
X Link 2025-07-24T11:01Z [----] followers, [---] engagements
"Dear psychedelic drug developers Do you want to improve the already solid data being generated in mid-late-stage programs Consider adding tracks from this album in music playlists used in your clinical trials. Best regards. Jake $CMPS $MNMD $CYBN $ATAI $GHRS"
X Link 2025-07-25T01:38Z [----] followers, [--] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing